CN106174561A - Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity - Google Patents
Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity Download PDFInfo
- Publication number
- CN106174561A CN106174561A CN201610541739.2A CN201610541739A CN106174561A CN 106174561 A CN106174561 A CN 106174561A CN 201610541739 A CN201610541739 A CN 201610541739A CN 106174561 A CN106174561 A CN 106174561A
- Authority
- CN
- China
- Prior art keywords
- parts
- curculigo
- immunity
- oral liquid
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 55
- 239000007788 liquid Substances 0.000 title claims abstract description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 81
- 239000000843 powder Substances 0.000 claims abstract description 24
- 238000005325 percolation Methods 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 16
- 239000012141 concentrate Substances 0.000 claims abstract description 11
- 229920001353 Dextrin Polymers 0.000 claims abstract description 6
- 239000004375 Dextrin Substances 0.000 claims abstract description 6
- 235000019425 dextrin Nutrition 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- 238000007598 dipping method Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract 6
- 239000003814 drug Substances 0.000 claims description 64
- 229940079593 drug Drugs 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 14
- 241000218176 Corydalis Species 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 239000010935 stainless steel Substances 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 230000008901 benefit Effects 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims 3
- 229910000831 Steel Inorganic materials 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000010959 steel Substances 0.000 claims 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 238000002481 ethanol extraction Methods 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 238000011068 loading method Methods 0.000 claims 1
- 239000012567 medical material Substances 0.000 claims 1
- 235000011837 pasties Nutrition 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000004577 thatch Substances 0.000 claims 1
- 241000234276 Curculigo Species 0.000 abstract description 85
- 210000000952 spleen Anatomy 0.000 abstract description 38
- 230000007812 deficiency Effects 0.000 abstract description 33
- 239000000284 extract Substances 0.000 abstract description 23
- 230000035922 thirst Effects 0.000 abstract description 14
- 235000013305 food Nutrition 0.000 abstract description 7
- 206010013781 dry mouth Diseases 0.000 abstract description 4
- 239000002245 particle Substances 0.000 abstract description 4
- 206010015958 Eye pain Diseases 0.000 abstract description 3
- 208000021792 sore eyes Diseases 0.000 abstract description 3
- 206010062519 Poor quality sleep Diseases 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 75
- 230000000694 effects Effects 0.000 description 67
- 210000004369 blood Anatomy 0.000 description 52
- 239000008280 blood Substances 0.000 description 52
- 210000003734 kidney Anatomy 0.000 description 49
- 230000006870 function Effects 0.000 description 33
- 241000282414 Homo sapiens Species 0.000 description 31
- 210000004185 liver Anatomy 0.000 description 29
- 241000700159 Rattus Species 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 20
- 229940040129 luteinizing hormone Drugs 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 19
- 102000009151 Luteinizing Hormone Human genes 0.000 description 18
- 108010073521 Luteinizing Hormone Proteins 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 16
- 240000005717 Dioscorea alata Species 0.000 description 15
- 235000002723 Dioscorea alata Nutrition 0.000 description 15
- 230000037396 body weight Effects 0.000 description 15
- 235000004879 dioscorea Nutrition 0.000 description 15
- 210000002216 heart Anatomy 0.000 description 15
- 210000001624 hip Anatomy 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 235000007056 Dioscorea composita Nutrition 0.000 description 14
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 14
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 14
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 14
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 14
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 14
- 241001570521 Lonicera periclymenum Species 0.000 description 14
- 244000241838 Lycium barbarum Species 0.000 description 14
- 235000015459 Lycium barbarum Nutrition 0.000 description 14
- 210000001744 T-lymphocyte Anatomy 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 238000001802 infusion Methods 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 238000002347 injection Methods 0.000 description 14
- 239000007928 intraperitoneal injection Substances 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 210000001541 thymus gland Anatomy 0.000 description 14
- 244000197580 Poria cocos Species 0.000 description 13
- 235000008599 Poria cocos Nutrition 0.000 description 13
- 208000002173 dizziness Diseases 0.000 description 13
- 230000036737 immune function Effects 0.000 description 13
- 239000002398 materia medica Substances 0.000 description 13
- 238000005728 strengthening Methods 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 230000036407 pain Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 11
- 208000009205 Tinnitus Diseases 0.000 description 11
- 231100000886 tinnitus Toxicity 0.000 description 11
- 241001061264 Astragalus Species 0.000 description 10
- 241000092665 Atractylodes macrocephala Species 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 10
- 241000893536 Epimedium Species 0.000 description 10
- 206010062767 Hypophysitis Diseases 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 10
- 241000405911 Rehmannia glutinosa Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000006533 astragalus Nutrition 0.000 description 10
- 235000018905 epimedium Nutrition 0.000 description 10
- 206010016256 fatigue Diseases 0.000 description 10
- 210000003127 knee Anatomy 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- 210000001672 ovary Anatomy 0.000 description 10
- 229960002275 pentobarbital sodium Drugs 0.000 description 10
- 210000003635 pituitary gland Anatomy 0.000 description 10
- 210000004233 talus Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 206010033557 Palpitations Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000001881 impotence Diseases 0.000 description 9
- 239000003488 releasing hormone Substances 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 8
- 235000008708 Morus alba Nutrition 0.000 description 8
- 206010059013 Nocturnal emission Diseases 0.000 description 8
- 206010057249 Phagocytosis Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 235000011034 Rubus glaucus Nutrition 0.000 description 8
- 235000009122 Rubus idaeus Nutrition 0.000 description 8
- 240000006079 Schisandra chinensis Species 0.000 description 8
- 235000008422 Schisandra chinensis Nutrition 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 230000001914 calming effect Effects 0.000 description 8
- 229960004397 cyclophosphamide Drugs 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000000987 immune system Anatomy 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 244000000010 microbial pathogen Species 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 230000008782 phagocytosis Effects 0.000 description 8
- 238000010791 quenching Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 229940126680 traditional chinese medicines Drugs 0.000 description 8
- 244000025254 Cannabis sativa Species 0.000 description 7
- 241000201295 Euphrasia Species 0.000 description 7
- 240000000249 Morus alba Species 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000001256 tonic effect Effects 0.000 description 7
- 240000000031 Achyranthes bidentata Species 0.000 description 6
- 241000220433 Albizia Species 0.000 description 6
- 206010002091 Anaesthesia Diseases 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 6
- 244000084791 Curculigo orchioides Species 0.000 description 6
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 206010061598 Immunodeficiency Diseases 0.000 description 6
- 235000015468 Lycium chinense Nutrition 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- LHNKBXRFNPMIBR-UHFFFAOYSA-N Picrotoxin Natural products CC(C)(O)C1(O)C2OC(=O)C1C3(O)C4OC4C5C(=O)OC2C35C LHNKBXRFNPMIBR-UHFFFAOYSA-N 0.000 description 6
- 241001165494 Rhodiola Species 0.000 description 6
- 240000007651 Rubus glaucus Species 0.000 description 6
- 230000037005 anaesthesia Effects 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 230000009545 invasion Effects 0.000 description 6
- VJKUPQSHOVKBCO-AHMKVGDJSA-N picrotoxin Chemical compound O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(=C)C)[C@@H]1C(=O)O2.O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(C)(O)C)[C@@H]1C(=O)O2 VJKUPQSHOVKBCO-AHMKVGDJSA-N 0.000 description 6
- 230000000171 quenching effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000004622 sleep time Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 235000011438 Albizia odoratissima Nutrition 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 244000042430 Rhodiola rosea Species 0.000 description 5
- 235000003713 Rhodiola rosea Nutrition 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 208000024765 knee pain Diseases 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000002028 premature Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 4
- 241000756943 Codonopsis Species 0.000 description 4
- 241000007126 Codonopsis pilosula Species 0.000 description 4
- 208000034656 Contusions Diseases 0.000 description 4
- 241000759833 Cornus officinalis Species 0.000 description 4
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000008967 Enuresis Diseases 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 102000023108 LH Receptors Human genes 0.000 description 4
- 108010011942 LH Receptors Proteins 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 241000607762 Shigella flexneri Species 0.000 description 4
- 206010041497 Spermatorrhoea Diseases 0.000 description 4
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000011362 coarse particle Substances 0.000 description 4
- 230000001143 conditioned effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- XGVJWXAYKUHDOO-UHFFFAOYSA-N galanthidine Natural products C1CN2CC3=CC=4OCOC=4C=C3C3C2C1=CC(O)C3O XGVJWXAYKUHDOO-UHFFFAOYSA-N 0.000 description 4
- 230000004727 humoral immunity Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- XGVJWXAYKUHDOO-DANNLKNASA-N lycorine Chemical compound C1CN2CC3=CC=4OCOC=4C=C3[C@H]3[C@H]2C1=C[C@H](O)[C@H]3O XGVJWXAYKUHDOO-DANNLKNASA-N 0.000 description 4
- KQAOMBGKIWRWNA-UHFFFAOYSA-N lycorine Natural products OC1C=C2CCN3C2C(C1O)c4cc5OCOc5cc34 KQAOMBGKIWRWNA-UHFFFAOYSA-N 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 4
- 230000003405 preventing effect Effects 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 230000011514 reflex Effects 0.000 description 4
- 210000001625 seminal vesicle Anatomy 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 230000002277 temperature effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 201000010653 vesiculitis Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000721662 Juniperus Species 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 244000170916 Paeonia officinalis Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000019804 backache Diseases 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 230000007937 eating Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000004153 glucose metabolism Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 208000033065 inborn errors of immunity Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 206010027175 memory impairment Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 description 2
- 240000007185 Albizia julibrissin Species 0.000 description 2
- 235000011468 Albizia julibrissin Nutrition 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 102100025841 Cholecystokinin Human genes 0.000 description 2
- 101800001982 Cholecystokinin Proteins 0.000 description 2
- 241000336291 Cistanche deserticola Species 0.000 description 2
- 206010053398 Clonic convulsion Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000209020 Cornus Species 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 240000007371 Cuscuta campestris Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 208000009386 Experimental Arthritis Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 108010040490 Gonadotropin Receptors Proteins 0.000 description 2
- 102000006771 Gonadotropins Human genes 0.000 description 2
- 241000096284 Gynochthodes officinalis Species 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000033830 Hot Flashes Diseases 0.000 description 2
- 206010060800 Hot flush Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027304 Menopausal symptoms Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 2
- 244000235659 Rubus idaeus Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 2
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000006136 alcoholysis reaction Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000006538 anaerobic glycolysis Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000004198 anterior pituitary gland Anatomy 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- -1 baicalein glucoside Chemical class 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940107137 cholecystokinin Drugs 0.000 description 2
- 108040005514 choriogonadotropin hormone receptor activity proteins Proteins 0.000 description 2
- 229940015047 chorionic gonadotropin Drugs 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 125000003306 cortisone group Chemical group 0.000 description 2
- 229940117173 croton oil Drugs 0.000 description 2
- WUOIMLIHAHOCCR-UHFFFAOYSA-N curculigoside Natural products COc1ccc(OC2OC(CO)C(O)C(O)C2O)c(OC)c1C(=O)OCc3cc(O)ccc3OC4OC(CO)C(O)C(O)C4O WUOIMLIHAHOCCR-UHFFFAOYSA-N 0.000 description 2
- SJJRKHVKAXVFJQ-UHFFFAOYSA-N curculigoside I Natural products COC1=CC=CC(OC)=C1C(=O)OCC1=CC(O)=CC=C1OC1C(O)C(O)C(O)C(CO)O1 SJJRKHVKAXVFJQ-UHFFFAOYSA-N 0.000 description 2
- SJJRKHVKAXVFJQ-QKYBYQKWSA-N curculigoside a Chemical compound COC1=CC=CC(OC)=C1C(=O)OCC1=CC(O)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 SJJRKHVKAXVFJQ-QKYBYQKWSA-N 0.000 description 2
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000002897 effect on convulsion Effects 0.000 description 2
- 230000000517 effect on sleep Effects 0.000 description 2
- 230000000674 effect on sodium Effects 0.000 description 2
- 230000007368 endocrine function Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003617 erythrocyte membrane Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000002622 gonadotropin Substances 0.000 description 2
- 229930187479 gypenoside Natural products 0.000 description 2
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000018299 prostration Diseases 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 210000003752 saphenous vein Anatomy 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 235000002727 Dioscorea praehensilis Nutrition 0.000 description 1
- 235000002726 Dioscorea rotundata Nutrition 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241001110058 Euphrasia pectinata Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000021129 Postpartum disease Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000006023 anti-tumor response Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000000649 b-lymphocyte subset Anatomy 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 208000025644 recurrent pneumonia Diseases 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000008678 sanqi Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种提高免疫力的仙茅口服液的制备方法,制备步骤包括:a.仙茅的萃取,作为组分1;b.将所述其余原料药放入乙醇中加热回流提取2次,作为组分2;c.将上述两种提取液组分1和组分2合并,浓缩后加糊精调和,消毒杀菌后制备成口服液剂。所述步骤a中,将采集的仙茅切碎,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉。本发明能较好的改善亚健康人群易感冒、眼睛酸涩、睡眠质量不高,脾虚乏力;食少口干;消渴。The invention discloses a preparation method of curculigo curculigo oral liquid for improving immunity. The preparation steps include: a. extracting curculigo curculiosa as component 1; b. putting the remaining raw materials into ethanol and heating and refluxing to extract 2. Second, as component 2; c. Combine the above two extracts, component 1 and component 2, concentrate, add dextrin to reconcile, and prepare oral liquid after disinfection. In the step a, chop the collected curculigo, then slowly add 70% ethanol solution; wait until the air between the powder particles is discharged, and about 20L of ethanol flows out, close the discharge valve, and cover the drum , Dipping for 24 hours, and then open the material valve for percolation. The invention can better improve sub-healthy people who are prone to colds, sore eyes, poor sleep quality, spleen deficiency and fatigue, lack of food, dry mouth and thirst.
Description
技术领域technical field
本发明涉及含有来源于植物组份的提高免疫力的保健品,特别涉及一种提高免疫力的仙茅口服液及其制备方法。The invention relates to a health product for improving immunity containing components derived from plants, in particular to a curculigo curculigo oral liquid for improving immunity and a preparation method thereof.
背景技术Background technique
中医学中没有“免疫力低下”这种说法,但有气虚、体虚等类似的概念。患者很容易出现感冒、咽喉炎、肺炎等感染症状,因为体内正气不足,外邪容易反复入侵。西医解释为免疫力低下,讲的是同一个意思,所以提高免疫力其实是中西医学共同追求的目标。There is no such term as "low immunity" in Chinese medicine, but there are similar concepts such as qi deficiency and physical weakness. Patients are prone to infection symptoms such as colds, pharyngitis, and pneumonia, because the body's righteousness is insufficient, and external evils are easy to invade repeatedly. Western medicine interprets it as low immunity, which means the same thing, so improving immunity is actually the goal pursued by both Chinese and Western medicine.
所谓免疫力,简单地说就是人体免于各种病原微生物侵害的能力。应该说在人类漫长的进化过程中,人类一直在同自然界中的各种致病微生物,包括病毒、细菌、真菌等作斗争。不管科学技术进步到什么程度,不管人类能发明多么先进的药物,人体自身免疫力仍将会继续发挥着重要作用。The so-called immunity, simply put, is the ability of the human body to avoid various pathogenic microorganisms. It should be said that in the long evolutionary process of human beings, human beings have been fighting against various pathogenic microorganisms in nature, including viruses, bacteria, fungi, etc. No matter how far science and technology advances, no matter how advanced medicines humans can invent, the body's own immunity will continue to play an important role.
人体免疫是人体对外界的病原微生物等的防御机能,或者说是防御系统,在正常情况下,它能够保证人体不受外界病原微生物的侵害。通常说的人体免疫力就是指人体的免疫系统抵御外来病原微生物等侵害的能力。在人体免疫力正常的情况下,人体自身能够抵御相当多的病菌的侵害,避免对人体造成损伤。免疫力在人体生命机制中发挥重要的作用,而人体的营养、劳累、心情、环境、疾病、用药、辐射等导致自身的免疫力下降。数百万年来,人类在生活一个既适合生存又充满危险的环境,人类得以存续,也获得了非凡的免疫力。所以说免疫力是生物进化过程的产物。Human immunity is the defense function of the human body against external pathogenic microorganisms, or the defense system. Under normal circumstances, it can ensure that the human body is not invaded by external pathogenic microorganisms. Generally speaking, human immunity refers to the ability of the human body's immune system to resist the invasion of foreign pathogenic microorganisms. Under the condition of normal human immunity, the human body itself can resist the invasion of quite a few germs and avoid causing damage to the human body. Immunity plays an important role in the mechanism of human life, and the human body's nutrition, fatigue, mood, environment, disease, medication, radiation, etc. lead to the decline of its own immunity. For millions of years, humans have lived in an environment that is both suitable for survival and fraught with danger. Human beings have survived and acquired extraordinary immunity. So immunity is a product of biological evolution.
免疫力低下的身体易于被感染或患癌症;免疫力超常也会产生对身体有害的结果,如引发过敏反应、自身免疫疾病等。各种原因使免疫系统不能正常发挥保护作用,在此情况下,极易招致细菌、病毒、真菌等感染,因此免疫力低下最直接的表现就是容易生病。因经常患病,加重了机体的消耗,所以一般有体质虚弱、营养不良、精神萎靡、疲乏无力、食欲降低、睡眠障碍等表现,生病、打针吃药便成了家常便饭。每次生病都要很长时间才能恢复,而且常常反复发作。长此以往会导致身体和智力发育不良,还易诱发重大疾病。深层原因是免疫力低下或免疫力不健全。当人体免疫功能失调,或者免疫系统不健全时,下列问题就会反复发作:--感冒反复发作、扁桃体炎反复发作、哮喘反复发作、支气管炎反复发作、肺炎反复发作、腹泻反复发作......所以千万不可小视。A body with a low immune system is prone to infection or cancer; an immune system with a high immune system can also produce harmful results, such as triggering allergic reactions, autoimmune diseases, etc. For various reasons, the immune system cannot normally play a protective role. In this case, it is very easy to cause infections such as bacteria, viruses, and fungi. Therefore, the most direct manifestation of low immunity is that it is easy to get sick. Due to frequent illnesses, the consumption of the body has been aggravated, so there are generally symptoms such as physical weakness, malnutrition, listlessness, fatigue, loss of appetite, sleep disturbance, etc. Getting sick, taking injections and taking medicine have become commonplace. It takes a long time to recover from each illness, and often relapses. If things go on like this, it can lead to poor physical and mental development, and it is also easy to induce major diseases. The underlying reason is low immunity or unsound immunity. When the human body's immune function is dysfunctional, or the immune system is not perfect, the following problems will recur: --recurrent colds, recurrent tonsillitis, recurrent asthma, recurrent bronchitis, recurrent pneumonia, recurrent diarrhea... ...so don't underestimate it.
免疫力是指机体抵抗外来侵袭,维护体内环境稳定性的能力。空气中充满了各种各样的微生物:细菌、病毒、支原体、衣原体、真菌等等。在人体免疫力低下的情况下,它们都可以成为感早班的病原体。虽然人体对不同的病原体会产生相应的抗体,以抵御再次感染,但抗体具有专一性和时限性,比如链球菌抗体只能在较短时期内保护机体不受链球菌的再次侵犯,也并不能抵御其他病毒的感染。免疫力低下的人根本无法抵御感冒病毒的侵袭,这才是易感人群频繁感冒的真正原因。Immunity refers to the ability of the body to resist external invasion and maintain the stability of the internal environment. The air is full of all kinds of microorganisms: bacteria, viruses, mycoplasma, chlamydia, fungi, etc. In the case of low human immunity, they can all become pathogens of the morning shift. Although the human body will produce corresponding antibodies against different pathogens to resist re-infection, antibodies are specific and time-limited. Can not resist other virus infection. People with low immunity cannot resist the invasion of cold viruses at all, which is the real reason why susceptible people often catch colds.
仙茅(学名:Curculigo orchioides Gaertn.),又名地棕(四川、贵州),独茅(四川),山党参(福建),仙茅参(云南),海南参(海南),茅爪子,婆罗门参,属仙茅科,花期4~9月。药用植物,具有补肾助阳、益精血、强筋骨和行血消肿的作用。仙茅能温肾阳壮;祛除寒湿。主阳萎精冷;小便失禁;脘腹冷痛;腰膝酸痛;筋骨软弱;下肢拘挛;更年期综合征。Curculigo orchioides (scientific name: Curculigo orchioides Gaertn.), also known as ground palm (Sichuan, Guizhou), monophyll (Sichuan), mountain codonopsis (Fujian), curculigo orchioides (Yunnan), Hainan ginseng (Hainan), Mao claw, Brahmin Ginseng belongs to Curculigoaceae, flowering period is from April to September. Medicinal plants have the functions of tonifying kidney and yang, benefiting essence and blood, strengthening muscles and bones, promoting blood circulation and reducing swelling. Curculigo can warm kidney and strengthen Yang; dispel cold and dampness. Indicates impotence and essence cold; urinary incontinence; epigastric cold and pain; waist and knee pain; weakness of muscles and bones; spasms of lower limbs; menopausal syndrome.
仙茅的药理作用Pharmacological effects of curculigo
对免疫功能作用effect on immune function
1、对巨噬细胞吞噬功能的影响:给小鼠灌服仙茅70%醇浸剂10,20g/kg,每天1次,连续7天,于给药后第5天分别腹腔注射0.4%肝糖原2ml,而于末次给药后1小时,腹腔注射2%鸡红血球悬液1ml,2小时后处死小鼠。按文献(张蕴芬等,北京医学院学报1979)法测定吞噬功能。结果表明仙茅可使小鼠腹腔巨噬细胞吞噬百分数与吞噬指数,均比对照组明显增加。1. Effects on the phagocytosis of macrophages: mice were fed with 70% curculigo infusion 10, 20g/kg, once a day, for 7 consecutive days, and on the fifth day after administration, 0.4% liver 2 ml of glycogen, and 1 ml of 2% chicken red blood cell suspension was intraperitoneally injected 1 hour after the last administration, and the mice were sacrificed 2 hours later. The phagocytic function was measured according to the literature (Zhang Yunfen et al., Journal of Beijing Medical College, 1979). The results showed that Curculigo curculigo can significantly increase the phagocytosis percentage and phagocytosis index of mouse peritoneal macrophages compared with the control group.
2、对正常及免疫功能抑制小鼠T淋巴细胞百分率的影响:采用酯酶法(南京铁道医学院组胚教研室中华医学杂志1980)测定小鼠T淋巴细胞百分率。结果证明,仙茅不能提高正常小鼠T淋巴细胞百分率,但对环磷酰胺所致免疫功能受抑制小鼠的T淋巴细胞的降低有明显的作用。2. Effects on the percentage of T lymphocytes in normal and immune-suppressed mice: The percentage of T lymphocytes in mice was determined by esterase method (Nanjing Railway Medical College Histoembryology Teaching and Research Office, Chinese Medical Journal, 1980). The results proved that Curculigo curculigo could not increase the percentage of T lymphocytes in normal mice, but it had a significant effect on the reduction of T lymphocytes in mice with immune function suppressed by cyclophosphamide.
3、仙茅水提物有促进抗体生成并延长其功效,仙茅甙促进巨噬细胞增生并提高其吞噬功能,可认为有增强免疫功能。3. The water extract of curculigo can promote the production of antibodies and prolong its efficacy. Curculigoside can promote the proliferation of macrophages and improve their phagocytosis, which can be considered to enhance immune function.
对中枢神经系统的作用Effects on the central nervous system
1、对戊巴比妥钠睡眠时间的影响:给小鼠腹腔注射仙茅醇浸剂10g/kg后30分钟,腹腔注射戊巴比妥钠40mg/kg,记录小鼠睡眠时间,结果给药组与对照组(生理盐水)小鼠的平均睡眠时间分别为304.9±24.2与63.4±11.6(分钟)。证明仙茅有明显延长睡眠时间作用(P<0.001)。1. Effect on sleep time of pentobarbital sodium: 30 minutes after intraperitoneal injection of curculigo alcohol infusion 10g/kg to mice, intraperitoneal injection of pentobarbital sodium 40mg/kg, recording sleep time of mice, and administration of results The average sleep time of the mice in the control group and the control group (normal saline) were 304.9±24.2 and 63.4±11.6 (minutes), respectively. It is proved that curculigo can significantly prolong sleep time (P<0.001).
2、对印防己毒素致惊厥作用的影响:给小鼠腹腔注射仙茅后30分钟,再腹腔注射印防己毒素200mg/kg,记录小鼠出现阵挛性惊厥的潜伏时间。结果表明,仙茅组和对照组出现惊厥的潜伏时间分别为24.38±3.78与7.57±0.63分钟,两组间差异非常显着(P<0.001)。说明仙茅对印防己毒素所致小鼠惊厥,能明显推迟其出现惊厥的潜伏期。2. The effect on convulsions induced by picrotoxin: 30 minutes after the intraperitoneal injection of Curculigo grass, 200 mg/kg of picrotoxin was injected intraperitoneally, and the latency time for the mice to appear clonic convulsions was recorded. The results showed that the latency time of convulsions in the curculiculatus group and the control group were 24.38±3.78 and 7.57±0.63 minutes respectively, and the difference between the two groups was very significant (P<0.001). It shows that curculigo can significantly delay the latent period of convulsions in mice induced by picrotoxin.
3、仙茅所含的石碱,给予大鼠腹腔注射5mg/kg,可显着延长其条件反射的潜伏期,使阳性条件反射部分消失而后恢复,给小鼠注射2mg/kg,有显着的镇静作用,剂量为12mg/kg可延长戊巴比妥的催眠时间,并有显着的镇痛和解热作用。3. The stone alkali contained in Curculigo curculigo can significantly prolong the latent period of its conditioned reflex by intraperitoneal injection of 5 mg/kg to rats, so that the positive conditioned reflex partially disappears and then recovers. Injecting 2 mg/kg into mice has a significant effect. Sedative effect, a dose of 12mg/kg can prolong the hypnotic time of pentobarbital, and has significant analgesic and antipyretic effects.
对下丘脑-垂体-性腺轴功能的作用Effects on hypothalamic-pituitary-gonadal axis function
1、对正常大白鼠垂体-卵巢内分泌功能的影响:用正常雌性大白鼠35只,体重150~200g,随机分为8组:仙茅组、菟丝子组、巴戟天组、熟地组、肉苁蓉组、淫羊藿组、枸杞子组和对照组。药物组(煎液)以灌胃给药,按1ml/100g体重,每日2次,连服5天。对照组灌胃同量生理盐水。第6天处理动物,在戊巴比妥钠麻醉下,由腹主动脉取血1ml,分离血浆,留作血浆黄体生成素(LH)测定。摘出垂体前叶、子宫和卵巢并称重,将卵巢立即投入冰冻之Tris-Hcl缓冲液中留作测定绒毛膜促性腺激素/黄体生成素受体。结果表明,仙茅等助阳补肾中药能使大白鼠垂体前叶重量、卵巢重量、子宫重量比对照组明显增重(P<0.01);但血浆中黄体生成素水平未见改变;卵巢绒毛膜促性腺激素/黄体生成素受体特异结合力服药组比对照组也明显提高(P<0.01)。1. Effects on endocrine function of pituitary gland and ovary in normal rats: 35 normal female rats, weighing 150-200g, were randomly divided into 8 groups: curculigo grass group, dodder group, Morinda officinalis group, Rehmannia glutinosa group, Cistanche deserticola group , Epimedium group, Lycium barbarum group and control group. The drug group (decoction) was administered by intragastric administration, 1ml/100g body weight, twice a day, for 5 days. The control group was intragastrically administered the same amount of normal saline. On the 6th day, the animals were treated, and under pentobarbital sodium anesthesia, 1 ml of blood was collected from the abdominal aorta, and the plasma was separated for determination of plasma luteinizing hormone (LH). The anterior lobe of the pituitary gland, uterus and ovary were removed and weighed, and the ovary was immediately put into the frozen Tris-Hcl buffer for determination of chorionic gonadotropin/luteinizing hormone receptor. The results showed that curculigo and other traditional Chinese medicines for promoting yang and tonifying kidney could significantly increase the weight of anterior pituitary gland, ovary and uterus in rats compared with the control group (P<0.01); but the level of luteinizing hormone in plasma did not change; The specific binding ability of gonadotropin/luteinizing hormone receptors in the medication group was also significantly higher than that in the control group (P<0.01).
2、对去卵巢大白鼠垂体对促黄体释放激素反应性的影响:实验设计参照JohnsonJH和Davis CL(1981)的方法。取35只成年健康雌性大白鼠,体重150~200g,在乙醚麻醉下切除双侧卵巢。1周后,随机分为8组,7组为相应各服药组,1组为对照组。每日灌胃给药2次,按1ml/100g体重,连服5天;对照组服同量生理盐水。第6天上午8点,用戊巴比妥钠皮下注射麻醉(50mg/kg),30分钟后,由腹腔静脉抽血0.4ml(肝素抗凝),然后由隐静脉注射D-丙-促黄体释放激素(100ng/100g体重)。在注射促黄体释放激素后30分钟和90分钟,由腹腔静脉各取血0.4ml。离心分离3次,所取血样之血浆留作黄体生成素测定,以判定垂体对注射促黄体释放激素后黄体生成素分泌反应。结果表明,各组动物在戊巴比妥钠麻醉下,血浆黄体生成素水平很低。注射了D-丙-促黄体释放激素后,对照组动物在30分钟时血浆黄体生成素水平增加到22.25ng/ml,90分钟时为18.50ng/ml。而服仙茅等助阳补肾中药的大白鼠,垂体对注射促黄体释放激素后黄体生成素分泌反应明显增加,注射后90分钟时血浆黄体生成素水平仙茅组为55.90ng/ml,比对照组明显增高(P<0.01)。2. Effects on the responsiveness of the pituitary gland of ovariectomized rats to luteinizing releasing hormone: the experimental design refers to the method of JohnsonJH and Davis CL (1981). Take 35 adult healthy female rats, weighing 150-200 g, and remove both ovaries under ether anesthesia. One week later, they were randomly divided into 8 groups, 7 groups were the corresponding medication groups, and 1 group was the control group. Oral administration twice a day, at 1ml/100g body weight, for 5 consecutive days; the control group took the same amount of normal saline. At 8 o'clock in the morning on the sixth day, anesthetize with pentobarbital sodium subcutaneous injection (50mg/kg), 30 minutes later, draw 0.4ml of blood from the abdominal cavity vein (heparin anticoagulant), and then inject D-alcohol-luteinizing hormone from the saphenous vein Release hormone (100ng/100g body weight). At 30 minutes and 90 minutes after the injection of luteinizing releasing hormone, 0.4 ml of blood was collected from the abdominal vein. After centrifugation for 3 times, the plasma of the blood sample was reserved for the determination of luteinizing hormone to determine the response of the pituitary gland to the secretion of luteinizing hormone after injection of luteinizing releasing hormone. The results showed that the levels of plasma luteinizing hormone in each group of animals were very low under pentobarbital sodium anesthesia. After injection of D-alpha-luteinizing releasing hormone, the plasma luteinizing hormone level in control animals increased to 22.25 ng/ml at 30 minutes and 18.50 ng/ml at 90 minutes. However, in the rats taking curculigo and other traditional Chinese medicines for strengthening yang and nourishing the kidney, the pituitary gland significantly increased the secretion of luteinizing hormone after injection of luteinizing releasing hormone, and the plasma luteinizing hormone level was 55.90 ng/ml at 90 minutes after injection, which was higher than that of the control group. group significantly increased (P <0.01).
雄性激素样作用androgen-like effect
取体重为60-90g的雄性大鼠16只,切除两侧睾丸,手术后第7天,分为2组,分别灌胃仙茅70%醇浸剂10g/kg与生理盐水,每天1次,连续21天。于末次给药后的次日,处死动物,剖出精囊腺称重。结果仙茅组与对照组大鼠的精囊腺重分别为0.116±0.009与0.0679±0.003mg/g体重,有显着差异(P<0.01)。说明仙茅有雄性激素样作用。Take 16 male rats with a body weight of 60-90g, remove the testes on both sides, divide them into two groups on the 7th day after the operation, and give 10g/kg of Curculigo grass 70% alcohol infusion and normal saline, once a day, respectively. 21 consecutive days. On the next day after the last administration, the animals were sacrificed, and the seminal vesicles were dissected out and weighed. Results The seminal vesicle weights of the curculigo and control groups were 0.116±0.009 and 0.0679±0.003mg/g body weight respectively, and there was a significant difference (P<0.01). It shows that curculigo has a male hormone-like effect.
适应原样作用Adaptation as-is
1、耐缺氧作用:给小鼠灌胃仙茅70%醇浸剂20和40g/kg,1小时后,将小鼠置于250ml带塞广口瓶中,密封瓶口,记录各组小鼠的存活时间。结果仙茅醇浸剂20g/kg、40g/kg组与对照组小鼠的存活时间分别为28.8±1.14、33.6±1.19和26.8±0.77(分钟,X±SE)。仙茅40g/kg有明显的抗缺氧作用(P<0.001)。1. Anti-hypoxia effect: gavage 20 and 40 g/kg of curculigo 70% alcohol infusion to the mice, and after 1 hour, place the mice in a 250ml jar with a stopper, seal the bottle mouth, and record the time of each group. Rat survival time. Results The survival time of the mice in the 20g/kg and 40g/kg curculigo alcohol infusion groups and the control group were 28.8±1.14, 33.6±1.19 and 26.8±0.77 (minutes, X±SE), respectively. Curculigo 40g/kg has obvious anti-hypoxia effect (P<0.001).
2、抗高温作用:给小鼠腹腔注射仙茅70%醇浸剂10g/kg,30分钟后,将其置于45±1℃的恒温箱内,以药物组与对照组小鼠的总数死亡一半为界,记录各组小鼠死亡率。结果仙茅组的20只小鼠中死亡5只(死亡率力25%),而对照组20只小鼠中,死亡14只(死亡率为70%),两组间差别显着(P<0.05)。说明仙茅有抗高温作用。2. Anti-high temperature effect: intraperitoneal injection of Curculigo 70% alcohol infusion 10g/kg to mice, and after 30 minutes, place it in an incubator at 45±1°C, and die with the total number of mice in the drug group and the control group Half was used as a boundary, and the death rate of mice in each group was recorded. 5 of the 20 mice in the curculigo curculigo group died (mortality rate 25%), while in the 20 mice of the control group, 14 died (the mortality rate was 70%), and the difference was significant between the two groups (P< 0.05). It shows that curculigo has anti-high temperature effect.
抗炎作用anti-inflammatory effect
给小鼠腹腔注射仙茅70%醇浸剂10g/kg,可的松50mg/kg及生理盐水,给药后30分钟以巴豆油致炎。结果仙茅组、可的松组与对照组小鼠耳片肿胀度分别为9.25±1.23mg、4.1±1.35mg与14±1.04mg。表明仙茅对小鼠实验性炎症有明显的抑制作用(P<0.05)。The mice were intraperitoneally injected with Curculigo 70% alcohol infusion 10g/kg, cortisone 50mg/kg and normal saline, and croton oil was used to induce inflammation 30 minutes after the administration. Results The swelling degrees of the ears of the mice in the curculiculatus group, the cortisone group and the control group were 9.25±1.23mg, 4.1±1.35mg and 14±1.04mg, respectively. It shows that curculigo can significantly inhibit the experimental inflammation of mice (P<0.05).
对红细胞膜Na(+)、K(+)-ATP酶活性的作用Effect on Na(+), K(+)-ATPase activity of erythrocyte membrane
给小鼠灌胃12%的仙茅等补益中药的水煎液6g/kg,每天1次,连续10天。对照组给予等容积的水。测定酶活性。结果表明仙茅等补益药均可升高Na(+)、K(+)-ATP酶的活性。The mice were fed with 12% water decoction of curculigo and other tonic traditional Chinese medicines at 6 g/kg, once a day, for 10 consecutive days. The control group was given an equal volume of water. Determination of enzyme activity. The results showed that tonic medicines such as curculigo can increase the activity of Na(+) and K(+)-ATPase.
抗菌作用antibacterial effect
100%煎剂用平板挖沟法,对史氏、福氏、宋氏痢疾杆菌有抑制作用。The 100% decoction has inhibitory effect on Shigella flexneri, Shigella flexneri and Shigella sonnii by using flat trenching method.
抗肿瘤作用Antitumor effect
仙茅的丙酮提取物对艾氏腹水癌实体型瘤有抑制作用。石蒜碱能抑制小鼠腹水癌细胞的无氧酵解,但不影响其气化有呼吸,由于癌细胞一般以无氧醇解为能量的主要来源,可认为仙茅对癌细胞的糖代谢有一定干扰功效。The acetone extract of curculigo has inhibitory effect on Ehrlich ascites carcinoma solid tumor. Lycorine can inhibit the anaerobic glycolysis of ascites cancer cells in mice, but it does not affect their gasification and respiration. Since cancer cells generally use anaerobic alcoholysis as the main source of energy, it can be considered that Curculigo curculigo can affect the glucose metabolism of cancer cells. There is a certain interference effect.
其他作用other role
仙茅水提取液可扩张冠脉,强心。给缓性心律失常家兔静脉注射6g/kg,可显着增加心率,使突变细胞数显着下降,使嘌呤系统转化酶活性抑制约20%,使胆囊收缩素抑制约80%,使甲状腺机能减退,病人血清的环-磷酸腺苷水平降低者回升,环-磷酸鸟苷水平升高者回降,环-磷酸腺苷/环-磷酸鸟苷比值趋于正常。给大鼠腹腔注射石蒜碱6mg/kg,可增加尿酸排泄,对小鼠肾脏琥珀酸脱氢酶有显着抑制作用,轻度降压,抗实验性关节炎。Curculigo curculigo water extract can dilate coronary arteries and strengthen the heart. Intravenous injection of 6g/kg to rabbits with slow arrhythmia can significantly increase heart rate, significantly reduce the number of mutant cells, inhibit the activity of purine system converting enzyme by about 20%, inhibit cholecystokinin by about 80%, and make thyroid function When the level of cyclic-adenosine monophosphate in the patient's serum decreases, the patient's serum cyclic-adenosine monophosphate level will rise, and if the level of cyclic-guanosine monophosphate is elevated, it will fall back, and the ratio of cyclic-adenosine-phosphate/cyclic-guanosine-phosphate tends to be normal. Intraperitoneal injection of lycorine 6mg/kg to rats can increase uric acid excretion, significantly inhibit mouse kidney succinate dehydrogenase, mildly lower blood pressure, and resist experimental arthritis.
中药气味清苦,很多人不愿长期服用;即使服用,是药三分毒,让人长期服用时也产生抗拒心理。怎么把仙茅的功效发挥到最大又不伤害人体,并且明显改善口感,使人能接受,是我们迫切需要解决的问题。The smell of traditional Chinese medicine is bitter, and many people do not want to take it for a long time; How to maximize the efficacy of Curculigo curculigo without harming the human body, and obviously improve the taste so that people can accept it is a problem that we urgently need to solve.
发明内容Contents of the invention
本发明所要解决的技术问题在于,现代人的免疫力正变得越来越脆弱,环境污染,作息不规律、生活节奏快、吃的不健康,不知节欲,造成各种疾病的发病率都在不断上升。尤其所谓的办公室一族,更是免疫力低下的高发人群。大部分人都是亚健康状态,在透支原本就不健康的身体。大部分人的症状为失眠多梦、易感冒、眼睛酸涩、脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚赢瘦;风癞癣疾。怎样找到安全有效的活性物质保健品,能大大提高免疫力,增强体质一直是人们期待解决问题的关键。仙茅有降血压,降血糖,降血脂,防止动脉粥样硬化,提高免疫力和抗菌等作用。仙茅,微温。归肝、肾经。补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴,有明显的利尿、降压、抗菌与升高血液白细胞的作用,对治疗肝肾亏损所致的眩晕耳鸣、腰酸等症及由于肾阴不足所致的遗精、尿频等症有明显疗效。又因其具有收敛止血功效被常用于妇女体虚所致的月经过多,崩漏带下等症,对男科、妇科的常见病均有很好的治疗作用,大量用于补益药物的生产。再加上一些口感清淡,不影响山茱萸味道的中药,不影响口感使人易于接受,能较好的达到提高免疫力的功效。The technical problem to be solved by the present invention is that the immunity of modern people is becoming more and more fragile, environmental pollution, irregular work and rest, fast pace of life, unhealthy eating, and lack of abstinence cause the incidence of various diseases to increase. constant increase. Especially the so-called office workers are high-risk groups with low immunity. Most people are in a sub-healthy state, overdrawing their unhealthy bodies. Symptoms of most people are insomnia and dreaminess, easy to catch a cold, sore eyes, spleen deficiency and weakness; lack of food, dry mouth; thirst; kidney deficiency, soreness of waist and knees; Leprosy. How to find safe and effective active substance health care products, which can greatly improve immunity and enhance physical fitness has always been the key to people's expectation to solve the problem. Curculigo curculigo can lower blood pressure, lower blood sugar, lower blood fat, prevent atherosclerosis, improve immunity and antibacterial effects. Curculigo, lukewarm. Return liver, kidney channel. Tonifying the liver and kidney, astringent essence is solidified. It is used for dizziness, tinnitus, waist and knee pain, impotence, nocturnal emission, enuresis, frequent urination, uterine bleeding, profuse sweating, prostration, internal heat and quenching thirst. It has obvious diuretic, antihypertensive, antibacterial and elevated blood white blood cell effects, and is beneficial to the treatment of liver and kidney deficiency. It has obvious curative effect on dizziness, tinnitus, backache and other diseases caused by kidney yin deficiency, such as spermatorrhea and frequent urination. Because of its astringent and hemostatic effect, it is often used for menorrhagia, metrorrhagia and leukorrhea caused by women's physical weakness. It has a good therapeutic effect on common diseases of andrology and gynecology, and is widely used in the production of tonic medicines. Coupled with some traditional Chinese medicines that have a light taste and do not affect the taste of dogwood, they are easy to accept without affecting the taste, and can better achieve the effect of improving immunity.
为解决上述技术难题,本发明提供一种提高免疫力的仙茅口服液,其所述口服液可以包括以下重量份的原料:仙茅10~50份,地骨皮10~20份,白术10~20份,熟地10~20份,红景天10~20份,淫羊藿10~20份,三七10~20份,黄芪10~20份,绞股蓝10~20份,五味子10~20份,合欢皮10~20份,覆盆子10~20份,茯苓10~20份,制首乌10~20份,桑葚10~20份,枸杞10~20份,小米草10~20份,山药10~20份,牛膝10~20份,赤芍10~20份,延胡索10~20份,金银花10~20份。In order to solve the above-mentioned technical problems, the present invention provides a Curculigo curculigo oral liquid for improving immunity. The oral liquid may include the following raw materials in parts by weight: 10-50 parts of Curculigo curculigo, 10-20 parts of Digupi, 10 parts of Atractylodes macrocephala ~20 parts, Rehmannia glutinosa 10~20 parts, Rhodiola 10~20 parts, Epimedium 10~20 parts, Panax notoginseng 10~20 parts, Astragalus 10~20 parts, Gynostemma 10~20 parts, Schisandra 10~20 parts , 10-20 parts of acacia bark, 10-20 parts of raspberry, 10-20 parts of poria cocos, 10-20 parts of Radix Polygoni Multiflori, 10-20 parts of mulberry, 10-20 parts of wolfberry, 10-20 parts of eyebright, 10 yams ~20 parts, Achyranthes bidentata 10~20 parts, Radix Paeoniae Rubra 10~20 parts, Corydalis Corydalis 10~20 parts, honeysuckle 10~20 parts.
所述提高免疫力的仙茅口服液,其所述口服液还可以包括以下重量份的原料:仙茅10~40份,地骨皮10~15份,白术10~15份,熟地10~15份,红景天10~15份,淫羊藿10~15份,三七10~15份,黄芪10~15份,绞股蓝10~15份,五味子10~15份,合欢皮10~15份,覆盆子10~15份,茯苓10~15份,制首乌10~20份,桑葚10~20份,枸杞10~20份,小米草10~20份,山药10~20份,牛膝10~20份,赤芍10~20份,延胡索10~20份,金银花10~20份。Said curculigo oral liquid for improving immunity, said oral liquid may also include the following raw materials in parts by weight: 10-40 parts of curculigo, 10-15 parts of Digupi, 10-15 parts of Atractylodes macrocephala, 10-15 parts of Rehmannia glutinosa 10-15 parts of Rhodiola, 10-15 parts of Epimedium, 10-15 parts of Panax notoginseng, 10-15 parts of Astragalus, 10-15 parts of Gynostemma, 10-15 parts of Schisandra, 10-15 parts of Albizia Bark, 10-15 parts of raspberry, 10-15 parts of Poria cocos, 10-20 parts of Radix Polygoni Multiflori, 10-20 parts of mulberry, 10-20 parts of wolfberry, 10-20 parts of eyebright, 10-20 parts of yam, 10-20 parts of Achyranthes bidentata 20 parts, 10-20 parts of Radix Paeoniae Rubra, 10-20 parts of Corydalis Corydalis, 10-20 parts of Honeysuckle.
所述提高免疫力的仙茅口服液,其所述口服液也可以包括以下重量份的原料:仙茅10~50份,地骨皮10~20份,白术10~20份,熟地10~20份,红景天10~20份,淫羊藿10~20份,三七10~20份,黄芪10~20份,绞股蓝10~20份,五味子10~20份,合欢皮10~20份,覆盆子10~20份,茯苓10~20份,制首乌10~15份,桑葚10~15份,枸杞10~15份,小米草10~15份,山药10~15份,牛膝10~15份,赤芍10~15份,延胡索10~15份,金银花10~15份。Said curculigo oral liquid for improving immunity, said oral liquid may also include the following raw materials in parts by weight: 10-50 parts of curculigo, 10-20 parts of Digupi, 10-20 parts of Atractylodes macrocephala, 10-20 parts of Rehmannia glutinosa 10-20 parts of rhodiola, 10-20 parts of epimedium, 10-20 parts of Panax notoginseng, 10-20 parts of astragalus, 10-20 parts of Jiaogulan, 10-20 parts of Schisandra chinensis, 10-20 parts of Albizia juniper, 10-20 parts of raspberry, 10-20 parts of Poria cocos, 10-15 parts of Radix Polygoni Multiflori, 10-15 parts of mulberry, 10-15 parts of wolfberry, 10-15 parts of eyebright, 10-15 parts of yam, 10-15 parts of Achyranthes bidentata 15 parts, 10-15 parts of Radix Paeoniae Rubra, 10-15 parts of Corydalis Corydalis, 10-15 parts of Honeysuckle.
为解决上述技术问题,本发明还提供一种提高免疫力的仙茅口服液的制备方法,其特征在于,所述口服液的制备步骤包括:In order to solve the above-mentioned technical problems, the present invention also provides a preparation method of curculigo curculigo oral liquid for improving immunity, characterized in that, the preparation steps of said oral liquid include:
a.仙茅的萃取,作为组分1;a. The extraction of curculigo, as component 1;
b.将所述其余原料药放入乙醇中加热回流提取2次,作为组分2;b. put the rest of the raw materials into ethanol and heat and reflux to extract twice, as component 2;
c.将上述两种提取液组分1和组分2合并,浓缩后加糊精调和,消毒杀菌后制备成口服液剂。c. Combining the above two extract components 1 and 2, concentrating, adding dextrin to reconcile, disinfecting and sterilizing to prepare an oral liquid.
所述步骤a中,可以将采集的仙茅切碎,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用,作为组分1。In the step a, the collected curculigo can be chopped, soaked and placed in a stainless steel bucket with a cover, add 70% ethanol solution, the mass is 0.8-1 times that of the coarse particles, stir evenly, keep it moist and airtight for 1 hour Above, fully expand; wrap the filter plate at the bottom of the percolation cylinder with a gauze bag and pave it flat, then mix and loosen the wet and expanded drug sample, then use a stainless steel spoon to fill the powder, and evenly put it into the percolation cylinder, pack 10 -12 cm thick, press evenly with a T-shaped rod, and then follow the above operation, load layer by layer, pressurize properly, the powder filling should not exceed 2/3 of the height of the percolation cylinder; the powder surface is covered with stainless steel holes Press the plate firmly, open the discharge valve under the percolation cylinder, put a container, and then slowly add 70% ethanol solution; after the air between the powder particles is discharged, and about 20L of ethanol flows out, close the discharge valve , cover the drum, soak for 24 hours, then open the material valve for percolation, control the percolation speed, generally 1000g medicinal materials flow out 2-3ml per minute, put the filtrate into the liquid storage tank, and pour the ethanol solution when emptying Put it into the liquid storage tank; combine the leachate and let it stand for later use as component 1.
所述步骤b中,可以将其余原料泡入10倍量乙醇中10-15天后,加热提取2次,每次1-2小时,去上清液,合并提取液,100-110目滤过,再经截流分子量为6000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分2。In the step b, the remaining raw materials can be soaked in 10 times the amount of ethanol for 10-15 days, then heated and extracted twice for 1-2 hours each time, the supernatant is removed, the extracts are combined, and filtered through 100-110 mesh. After ultrafiltration through an ultrafiltration column with a cut-off molecular weight of 6000-10000, the ultrafiltrate is concentrated under reduced pressure to an extract with a relative density of 1.36 at 80°C, heated and concentrated to a paste, and left to stand for later use to form component 2.
所述步骤c中,可以将上述步骤提取的提取液,放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,加糊精调和,消毒杀菌后制备成口服液剂。In the step c, the extract extracted in the above steps can be mixed in a double-effect vacuum concentrator, and the filtrate is first concentrated to a concentrated solution with a relative density of 1.32 at 80°C, and then refrigerated at 0-5°C for 24 hours Add 0.3% diatomite filter aid to the refrigerated liquid, filter, put the filtrate into a double-effect vacuum concentrator, concentrate to contain 0.1g extract per 1ml, add dextrin to reconcile, and prepare oral liquid after sterilization agent.
为解决上述技术问题,本发明也提供一种提高免疫力的仙茅口服液的制备方法,其制备步骤还可以为:In order to solve the above-mentioned technical problems, the present invention also provides a preparation method of Curculigo curculigo Oral Liquid for improving immunity, and its preparation steps can also be:
a.仙茅的制备,作为组分1;a. The preparation of curculigo, as component 1;
b.将所述其余原料药切碎提取作为组分2;b. chopping and extracting the rest of the raw materials as component 2;
c.将组分1和组分2混合,浓缩后加适量蜂蜜调和,紫外线消毒杀菌后装瓶。c. Mix component 1 and component 2, concentrate and add appropriate amount of honey to blend, sterilize with ultraviolet light and bottle.
所述步骤a中,可以将采集的仙茅放入5-10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过;再将上述乙醇提取过的其他原料药的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇,并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,为组分1。In the step a, the collected curculigo can be put into 5-10 times the amount of ethanol, soaked for 1-2 hours, heated and extracted twice, each time for 1-2 hours, the supernatant is removed, and the extract is combined, 100 Filter through -120 mesh; then add 10 times the amount of water to heat and reflux the dregs of other raw materials extracted by ethanol to extract twice, each time for 1 to 2 hours, combine the two extracts and let stand; combine the above two Combine the extracts, recover ethanol under reduced pressure, and concentrate to a concentration of 0.6g crude drug/mL. After suction filtration, the relative density of the filtrate is about 1.08 at 20°C; reduce the pressure to 0.03-0.08MPa, and keep the temperature at 60- 80 ℃, concentrated to a relative density of 1.20, the temperature of the extract at 60 ℃ -70 ℃, component 1.
所述步骤b中,可以将其余原料药材混合,切碎过100~120目筛,过筛后细粉备用,粗颗粒放入耐酸碱浸渍锅,在室温下,与70度以上乙醇一起浸渍15~30天,然后加热回流提取2次,每次1~2小时,将2次提取液合并静置,过滤,分离后取滤液;用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状成为组分2。In the step b, the remaining raw materials and medicinal materials can be mixed, chopped and passed through a 100-120 mesh sieve, and the fine powder is used after sieving, and the coarse particles are put into an acid and alkali resistant dipping pot, and dipped together with ethanol above 70 degrees at room temperature 15-30 days, then heat and reflux extraction twice, each time for 1-2 hours, combine the two extracts and let stand, filter, separate and take the filtrate; filter with gauze, add 50-60% ethanol to the residue, 60°C Continue to extract at -70°C for 2 hours, stir once every 10 minutes, filter through gauze, combine the extracts, concentrate into a paste and become component 2.
本发明有益的技术效果在于,本发明具有无毒、能被生物体完全吸收的优点。仙茅有降血压,降血糖,降血脂,防止动脉粥样硬化,提高免疫力和抗菌等作用。仙茅微温。归肝、肾经。补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴,有明显的利尿、降压、抗菌与升高血液白细胞的作用,对治疗肝肾亏损所致的眩晕耳鸣、腰酸等症及由于肾阴不足所致的遗精、尿频等症有明显疗效;再加上一些活血化瘀,健脾利湿养阴的中药材,这些药材大多口感清淡,不影响山茱萸茶的味道,没有难闻难以下咽的中药味,使人易于接受,可以长期服用,能较好的改善亚健康人群易感冒、眼睛酸涩、睡眠质量不高,脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚赢瘦;风癞癣疾的症状,能较好的达到提高免疫力的功效。The beneficial technical effect of the invention lies in that the invention has the advantages of non-toxicity and being able to be completely absorbed by organisms. Curculigo curculigo can lower blood pressure, lower blood sugar, lower blood fat, prevent atherosclerosis, improve immunity and antibacterial effects. Curculigo lukewarm. Return liver, kidney channel. Tonifying the liver and kidney, astringent essence is solidified. It is used for dizziness, tinnitus, waist and knee pain, impotence, nocturnal emission, enuresis, frequent urination, uterine bleeding, profuse sweating, prostration, internal heat and quenching thirst. It has obvious diuretic, antihypertensive, antibacterial and elevated blood white blood cell effects, and is beneficial to the treatment of liver and kidney deficiency. Dizziness, tinnitus, backache and other symptoms caused by kidney yin deficiency, nocturnal emission, frequent urination and other symptoms have obvious curative effects; plus some Chinese medicinal materials that promote blood circulation, invigorate the spleen, dampness and nourish yin, most of these medicinal materials have a light taste, It does not affect the taste of Cornus officinalis tea, and has no unpleasant smell of traditional Chinese medicine that is difficult to swallow. It is easy to accept and can be taken for a long time. It can better improve sub-healthy people who are prone to colds, sore eyes, poor sleep quality, spleen deficiency and fatigue; eating less Dry mouth, thirst, kidney deficiency, soreness of the waist and knees, impotence, nocturnal emission, tinnitus, dark eyes, premature graying of beard and hair, body weakness and thinness, wind, leprosy and ringworm, can better achieve the effect of improving immunity.
具体实施方式detailed description
人体免疫是人体对外界的病原微生物等的防御机能,或者说是防御系统,在正常情况下,它能够保证人体不受外界病原微生物的侵害。通常说的人体免疫力就是指人体的免疫系统抵御外来病原微生物等侵害的能力。在人体免疫力正常的情况下,人体自身能够抵御相当多的病菌的侵害,避免对人体造成损伤。免疫力在人体生命机制中发挥重要的作用,而人体的营养、劳累、心情、环境、疾病、用药、辐射等导致自身的免疫力下降。越来越多研究表明,中药对人体免疫力的调节越来越发挥重要作用。Human immunity is the defense function of the human body against external pathogenic microorganisms, or the defense system. Under normal circumstances, it can ensure that the human body is not invaded by external pathogenic microorganisms. Generally speaking, human immunity refers to the ability of the human body's immune system to resist the invasion of foreign pathogenic microorganisms. Under the condition of normal human immunity, the human body itself can resist the invasion of quite a few germs and avoid causing damage to the human body. Immunity plays an important role in the mechanism of human life, and the human body's nutrition, fatigue, mood, environment, disease, medication, radiation, etc. lead to the decline of its own immunity. More and more studies have shown that traditional Chinese medicine is playing an increasingly important role in the regulation of human immunity.
仙茅(学名:Curculigo orchioides Gaertn.),又名地棕(四川、贵州),独茅(四川),山党参(福建),仙茅参(云南),海南参(海南),茅爪子,婆罗门参,属仙茅科,花期4~9月。药用植物,具有补肾助阳、益精血、强筋骨和行血消肿的作用。仙茅能温肾阳壮;祛除寒湿。主阳萎精冷;小便失禁;脘腹冷痛;腰膝酸痛;筋骨软弱;下肢拘挛;更年期综合征。Curculigo orchioides (scientific name: Curculigo orchioides Gaertn.), also known as ground palm (Sichuan, Guizhou), monophyll (Sichuan), mountain codonopsis (Fujian), curculigo orchioides (Yunnan), Hainan ginseng (Hainan), Mao claw, Brahmin Ginseng belongs to Curculigoaceae, flowering period is from April to September. Medicinal plants have the functions of tonifying kidney and yang, benefiting essence and blood, strengthening muscles and bones, promoting blood circulation and reducing swelling. Curculigo can warm kidney and strengthen Yang; dispel cold and dampness. Indicates impotence and essence cold; urinary incontinence; epigastric cold and pain; waist and knee pain; weakness of muscles and bones; spasms of lower limbs; menopausal syndrome.
仙茅的药理作用Pharmacological effects of curculigo
对免疫功能作用effect on immune function
1、对巨噬细胞吞噬功能的影响:给小鼠灌服仙茅70%醇浸剂10,20g/kg,每天1次,连续7天,于给药后第5天分别腹腔注射0.4%肝糖原2ml,而于末次给药后1小时,腹腔注射2%鸡红血球悬液1ml,2小时后处死小鼠。按文献(张蕴芬等,北京医学院学报1979)法测定吞噬功能。结果表明仙茅可使小鼠腹腔巨噬细胞吞噬百分数与吞噬指数,均比对照组明显增加。1. Effects on the phagocytosis of macrophages: mice were fed with 70% curculigo infusion 10, 20g/kg, once a day, for 7 consecutive days, and on the fifth day after administration, 0.4% liver 2 ml of glycogen, and 1 ml of 2% chicken red blood cell suspension was intraperitoneally injected 1 hour after the last administration, and the mice were sacrificed 2 hours later. The phagocytic function was measured according to the literature (Zhang Yunfen et al., Journal of Beijing Medical College, 1979). The results showed that Curculigo curculigo can significantly increase the phagocytosis percentage and phagocytosis index of mouse peritoneal macrophages compared with the control group.
2、对正常及免疫功能抑制小鼠T淋巴细胞百分率的影响:采用酯酶法(南京铁道医学院组胚教研室中华医学杂志1980)测定小鼠T淋巴细胞百分率。结果证明,仙茅不能提高正常小鼠T淋巴细胞百分率,但对环磷酰胺所致免疫功能受抑制小鼠的T淋巴细胞的降低有明显的作用。2. Effects on the percentage of T lymphocytes in normal and immune-suppressed mice: The percentage of T lymphocytes in mice was determined by esterase method (Nanjing Railway Medical College Histoembryology Teaching and Research Office, Chinese Medical Journal, 1980). The results proved that Curculigo curculigo could not increase the percentage of T lymphocytes in normal mice, but it had a significant effect on the reduction of T lymphocytes in mice with immune function suppressed by cyclophosphamide.
3、仙茅水提物有促进抗体生成并延长其功效,仙茅甙促进巨噬细胞增生并提高其吞噬功能,可认为有增强免疫功能。3. The water extract of curculigo can promote the production of antibodies and prolong its efficacy. Curculigoside can promote the proliferation of macrophages and improve their phagocytosis, which can be considered to enhance immune function.
对中枢神经系统的作用Effects on the central nervous system
1、对戊巴比妥钠睡眠时间的影响:给小鼠腹腔注射仙茅醇浸剂10g/kg后30分钟,腹腔注射戊巴比妥钠40mg/kg,记录小鼠睡眠时间,结果给药组与对照组(生理盐水)小鼠的平均睡眠时间分别为304.9±24.2与63.4±11.6(分钟)。证明仙茅有明显延长睡眠时间作用(P<0.001)。1. Effect on sleep time of pentobarbital sodium: 30 minutes after intraperitoneal injection of curculigo alcohol infusion 10g/kg to mice, intraperitoneal injection of pentobarbital sodium 40mg/kg, recording sleep time of mice, and administration of results The average sleep time of the mice in the control group and the control group (normal saline) were 304.9±24.2 and 63.4±11.6 (minutes), respectively. It is proved that curculigo can significantly prolong sleep time (P<0.001).
2、对印防己毒素致惊厥作用的影响:给小鼠腹腔注射仙茅后30分钟,再腹腔注射印防己毒素200mg/kg,记录小鼠出现阵挛性惊厥的潜伏时间。结果表明,仙茅组和对照组出现惊厥的潜伏时间分别为24.38±3.78与7.57±0.63分钟,两组间差异非常显着(P<0.001)。说明仙茅对印防己毒素所致小鼠惊厥,能明显推迟其出现惊厥的潜伏期。2. The effect on convulsions induced by picrotoxin: 30 minutes after the intraperitoneal injection of Curculigo grass, 200 mg/kg of picrotoxin was injected intraperitoneally, and the latency time for the mice to appear clonic convulsions was recorded. The results showed that the latency time of convulsions in the curculiculatus group and the control group were 24.38±3.78 and 7.57±0.63 minutes respectively, and the difference between the two groups was very significant (P<0.001). It shows that curculigo can significantly delay the latent period of convulsions in mice induced by picrotoxin.
3、仙茅所含的石碱,给予大鼠腹腔注射5mg/kg,可显着延长其条件反射的潜伏期,使阳性条件反射部分消失而后恢复,给小鼠注射2mg/kg,有显着的镇静作用,剂量为12mg/kg可延长戊巴比妥的催眠时间,并有显着的镇痛和解热作用。3. The stone alkali contained in Curculigo curculigo can significantly prolong the latent period of its conditioned reflex by intraperitoneal injection of 5 mg/kg to rats, so that the positive conditioned reflex partially disappears and then recovers. Injecting 2 mg/kg into mice has a significant effect. Sedative effect, a dose of 12mg/kg can prolong the hypnotic time of pentobarbital, and has significant analgesic and antipyretic effects.
对下丘脑-垂体-性腺轴功能的作用Effects on hypothalamic-pituitary-gonadal axis function
1、对正常大白鼠垂体-卵巢内分泌功能的影响:用正常雌性大白鼠35只,体重150~200g,随机分为8组:仙茅组、菟丝子组、巴戟天组、熟地组、肉苁蓉组、淫羊藿组、枸杞子组和对照组。药物组(煎液)以灌胃给药,按1ml/100g体重,每日2次,连服5天。对照组灌胃同量生理盐水。第6天处理动物,在戊巴比妥钠麻醉下,由腹主动脉取血1ml,分离血浆,留作血浆黄体生成素(LH)测定。摘出垂体前叶、子宫和卵巢并称重,将卵巢立即投入冰冻之Tris-Hcl缓冲液中留作测定绒毛膜促性腺激素/黄体生成素受体。结果表明,仙茅等助阳补肾中药能使大白鼠垂体前叶重量、卵巢重量、子宫重量比对照组明显增重(P<0.01);但血浆中黄体生成素水平未见改变;卵巢绒毛膜促性腺激素/黄体生成素受体特异结合力服药组比对照组也明显提高(P<0.01)。1. Effects on endocrine function of pituitary gland and ovary in normal rats: 35 normal female rats, weighing 150-200g, were randomly divided into 8 groups: curculigo grass group, dodder group, Morinda officinalis group, Rehmannia glutinosa group, Cistanche deserticola group , Epimedium group, Lycium barbarum group and control group. The drug group (decoction) was administered by intragastric administration, 1ml/100g body weight, twice a day, for 5 days. The control group was intragastrically administered the same amount of normal saline. On the 6th day, the animals were treated, and under pentobarbital sodium anesthesia, 1 ml of blood was collected from the abdominal aorta, and the plasma was separated for determination of plasma luteinizing hormone (LH). The anterior lobe of the pituitary gland, uterus and ovary were removed and weighed, and the ovary was immediately put into the frozen Tris-Hcl buffer for determination of chorionic gonadotropin/luteinizing hormone receptor. The results showed that curculigo and other traditional Chinese medicines for promoting yang and tonifying kidney could significantly increase the weight of anterior pituitary gland, ovary and uterus in rats compared with the control group (P<0.01); but the level of luteinizing hormone in plasma did not change; The specific binding ability of gonadotropin/luteinizing hormone receptors in the medication group was also significantly higher than that in the control group (P<0.01).
2、对去卵巢大白鼠垂体对促黄体释放激素反应性的影响:实验设计参照JohnsonJH和Davis CL(1981)的方法。取35只成年健康雌性大白鼠,体重150~200g,在乙醚麻醉下切除双侧卵巢。1周后,随机分为8组,7组为相应各服药组,1组为对照组。每日灌胃给药2次,按1ml/100g体重,连服5天;对照组服同量生理盐水。第6天上午8点,用戊巴比妥钠皮下注射麻醉(50mg/kg),30分钟后,由腹腔静脉抽血0.4ml(肝素抗凝),然后由隐静脉注射D-丙-促黄体释放激素(100ng/100g体重)。在注射促黄体释放激素后30分钟和90分钟,由腹腔静脉各取血0.4ml。离心分离3次,所取血样之血浆留作黄体生成素测定,以判定垂体对注射促黄体释放激素后黄体生成素分泌反应。结果表明,各组动物在戊巴比妥钠麻醉下,血浆黄体生成素水平很低。注射了D一丙一促黄体释放激素后,对照组动物在30分钟时血浆黄体生成素水平增加到22.25ng/ml,90分钟时为18.50ng/ml。而服仙茅等助阳补肾中药的大白鼠,垂体对注射促黄体释放激素后黄体生成素分泌反应明显增加,注射后90分钟时血浆黄体生成素水平仙茅组为55.90ng/ml,比对照组明显增高(P<0.01)。2. Effects on the responsiveness of the pituitary gland of ovariectomized rats to luteinizing releasing hormone: the experimental design refers to the method of JohnsonJH and Davis CL (1981). Take 35 adult healthy female rats, weighing 150-200 g, and remove both ovaries under ether anesthesia. One week later, they were randomly divided into 8 groups, 7 groups were the corresponding medication groups, and 1 group was the control group. Oral administration twice a day, at 1ml/100g body weight, for 5 consecutive days; the control group took the same amount of normal saline. At 8 o'clock in the morning on the sixth day, anesthetize with pentobarbital sodium subcutaneous injection (50mg/kg), 30 minutes later, draw 0.4ml of blood from the abdominal cavity vein (heparin anticoagulant), and then inject D-alcohol-luteinizing hormone from the saphenous vein Release hormone (100ng/100g body weight). At 30 minutes and 90 minutes after the injection of luteinizing releasing hormone, 0.4 ml of blood was collected from the abdominal vein. After centrifugation for 3 times, the plasma of the blood sample was reserved for the determination of luteinizing hormone to determine the response of the pituitary gland to the secretion of luteinizing hormone after injection of luteinizing releasing hormone. The results showed that the levels of plasma luteinizing hormone in each group of animals were very low under pentobarbital sodium anesthesia. After injection of D-C-LH, the plasma LH level of the animals in the control group increased to 22.25 ng/ml at 30 minutes and 18.50 ng/ml at 90 minutes. However, in the rats taking curculigo and other traditional Chinese medicines for strengthening yang and nourishing the kidney, the pituitary gland significantly increased the secretion of luteinizing hormone after injection of luteinizing releasing hormone, and the plasma luteinizing hormone level was 55.90 ng/ml at 90 minutes after injection, which was higher than that of the control group. group significantly increased (P <0.01).
雄性激素样作用androgen-like effect
取体重为60-90g的雄性大鼠16只,切除两侧睾丸,手术后第7天,分为2组,分别灌胃仙茅70%醇浸剂10g/kg与生理盐水,每天1次,连续21天。于末次给药后的次日,处死动物,剖出精囊腺称重。结果仙茅组与对照组大鼠的精囊腺重分别为0.116±0.009与0.0679±0.003mg/g体重,有显着差异(P<0.01)。说明仙茅有雄性激素样作用。Take 16 male rats with a body weight of 60-90g, remove the testes on both sides, divide them into two groups on the 7th day after the operation, and give 10g/kg of Curculigo grass 70% alcohol infusion and normal saline, once a day, respectively. 21 consecutive days. On the next day after the last administration, the animals were sacrificed, and the seminal vesicles were dissected out and weighed. Results The seminal vesicle weights of the curculigo and control groups were 0.116±0.009 and 0.0679±0.003mg/g body weight respectively, and there was a significant difference (P<0.01). It shows that curculigo has a male hormone-like effect.
适应原样作用Adaptation as-is
1、耐缺氧作用:给小鼠灌胃仙茅70%醇浸剂20和40g/kg,1小时后,将小鼠置于250ml带塞广口瓶中,密封瓶口,记录各组小鼠的存活时间。结果仙茅醇浸剂20g/kg、40g/kg组与对照组小鼠的存活时间分别为28.8±1.14、33.6±1.19和26.8±0.77(分钟,X±SE)。仙茅40g/kg有明显的抗缺氧作用(P<0.001)。1. Anti-hypoxia effect: gavage 20 and 40 g/kg of curculigo 70% alcohol infusion to the mice, and after 1 hour, place the mice in a 250ml jar with a stopper, seal the bottle mouth, and record the time of each group. Rat survival time. Results The survival time of the mice in the 20g/kg and 40g/kg curculigo alcohol infusion groups and the control group were 28.8±1.14, 33.6±1.19 and 26.8±0.77 (minutes, X±SE), respectively. Curculigo 40g/kg has obvious anti-hypoxia effect (P<0.001).
2、抗高温作用:给小鼠腹腔注射仙茅70%醇浸剂10g/kg,30分钟后,将其置于45±1℃的恒温箱内,以药物组与对照组小鼠的总数死亡一半为界,记录各组小鼠死亡率。结果仙茅组的20只小鼠中死亡5只(死亡率力25%),而对照组20只小鼠中,死亡14只(死亡率为70%),两组间差别显着(P<0.05)。说明仙茅有抗高温作用。2. Anti-high temperature effect: intraperitoneal injection of Curculigo 70% alcohol infusion 10g/kg to mice, and after 30 minutes, place it in an incubator at 45±1°C, and die with the total number of mice in the drug group and the control group Half was used as a boundary, and the death rate of mice in each group was recorded. 5 of the 20 mice in the curculigo curculigo group died (mortality rate 25%), while in the 20 mice of the control group, 14 died (the mortality rate was 70%), and the difference was significant between the two groups (P< 0.05). It shows that curculigo has anti-high temperature effect.
抗炎作用anti-inflammatory effect
给小鼠腹腔注射仙茅70%醇浸剂10g/kg,可的松50mg/kg及生理盐水,给药后30分钟以巴豆油致炎。结果仙茅组、可的松组与对照组小鼠耳片肿胀度分别为9.25±1.23mg、4.1±1.35mg与14±1.04mg。表明仙茅对小鼠实验性炎症有明显的抑制作用(P<0.05)。The mice were intraperitoneally injected with Curculigo 70% alcohol infusion 10g/kg, cortisone 50mg/kg and normal saline, and croton oil was used to induce inflammation 30 minutes after the administration. Results The swelling degrees of the ears of the mice in the curculiculatus group, the cortisone group and the control group were 9.25±1.23mg, 4.1±1.35mg and 14±1.04mg, respectively. It shows that curculigo can significantly inhibit the experimental inflammation of mice (P<0.05).
对红细胞膜Na(+)、K(+)-ATP酶活性的作用Effect on Na(+), K(+)-ATPase activity of erythrocyte membrane
给小鼠灌胃12%的仙茅等补益中药的水煎液6g/kg,每天1次,连续10天。对照组给予等容积的水。测定酶活性。结果表明仙茅等补益药均可升高Na(+)、K(+)-ATP酶的活性。The mice were fed with 12% water decoction of curculigo and other tonic traditional Chinese medicines at 6 g/kg, once a day, for 10 consecutive days. The control group was given an equal volume of water. Determination of enzyme activity. The results showed that tonic medicines such as curculigo can increase the activity of Na(+) and K(+)-ATPase.
抗菌作用antibacterial effect
100%煎剂用平板挖沟法,对史氏、福氏、宋氏痢疾杆菌有抑制作用。The 100% decoction has inhibitory effect on Shigella flexneri, Shigella flexneri and Shigella sonnii by using flat trenching method.
抗肿瘤作用Antitumor effect
仙茅的丙酮提取物对艾氏腹水癌实体型瘤有抑制作用。石蒜碱能抑制小鼠腹水癌细胞的无氧酵解,但不影响其气化有呼吸,由于癌细胞一般以无氧醇解为能量的主要来源,可认为仙茅对癌细胞的糖代谢有一定干扰功效。The acetone extract of curculigo has inhibitory effect on Ehrlich ascites carcinoma solid tumor. Lycorine can inhibit the anaerobic glycolysis of ascites cancer cells in mice, but it does not affect their gasification and respiration. Since cancer cells generally use anaerobic alcoholysis as the main source of energy, it can be considered that Curculigo curculigo can affect the glucose metabolism of cancer cells. There is a certain interference effect.
其他作用other role
仙茅水提取液可扩张冠脉,强心。给缓性心律失常家兔静脉注射6g/kg,可显着增加心率,使突变细胞数显着下降,使嘌呤系统转化酶活性抑制约20%,使胆囊收缩素抑制约80%,使甲状腺机能减退,病人血清的环-磷酸腺苷水平降低者回升,环-磷酸鸟苷水平升高者回降,环-磷酸腺苷/环-磷酸鸟苷比值趋于正常。给大鼠腹腔注射石蒜碱6mg/kg,可增加尿酸排泄,对小鼠肾脏琥珀酸脱氢酶有显着抑制作用,轻度降压,抗实验性关节炎Curculigo curculigo water extract can dilate coronary arteries and strengthen the heart. Intravenous injection of 6g/kg to rabbits with slow arrhythmia can significantly increase heart rate, significantly reduce the number of mutant cells, inhibit the activity of purine system converting enzyme by about 20%, inhibit cholecystokinin by about 80%, and make thyroid function When the level of cyclic-adenosine monophosphate in the patient's serum decreases, the patient's serum cyclic-adenosine monophosphate level will rise, and if the level of cyclic-guanosine monophosphate is elevated, it will fall back, and the ratio of cyclic-adenosine-phosphate/cyclic-guanosine-phosphate tends to be normal. Intraperitoneal injection of lycorine 6mg/kg to rats can increase uric acid excretion, significantly inhibit mouse kidney succinate dehydrogenase, mildly lower blood pressure, and resist experimental arthritis
党参为中国常用的传统补益药,古代以山西上党地区出产的党参为上品,具有补中益气,健脾益肺之功效。现代研究,党参含多种糖类、酚类、甾醇、挥发油、黄芩素葡萄糖甙、皂甙及微量生物碱,具有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。党参具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。《本草从新》记载:“补中益气、和脾胃、除烦渴。中气微弱,用以调补,甚为平妥。”Codonopsis Codonopsis is a traditional tonic medicine commonly used in China. In ancient times, Codonopsis Codonopsis produced in Shangdang area of Shanxi was the top grade. It has the effects of nourishing the middle and Qi, strengthening the spleen and lungs. Modern research shows that Codonopsis pilosula contains various sugars, phenols, sterols, volatile oils, baicalein glucoside, saponins and trace alkaloids, which have the functions of enhancing immunity, dilating blood vessels, lowering blood pressure, improving microcirculation, and enhancing hematopoietic function. In addition, it can improve the leukopenia caused by chemotherapy and radiotherapy. Codonopsis pilosula has the effects of invigorating the middle and replenishing qi, invigorating the spleen and benefiting the lungs. For weakness of the spleen and lung, shortness of breath and palpitations, lack of food and loose stools, asthma and cough due to deficiency, internal heat and quenching thirst, etc. "Materia Medica Congxin" records: "Replenishing the middle and replenishing qi, harmonizing the spleen and stomach, and relieving polydipsia. The middle qi is weak, and it is very safe to use it for tonifying."
茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。用于脾虚泄泻,带下茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用茯苓有标本兼顾之效,常与党参、白术、山药等配伍。有可用为补肺脾,治气虚之辅佐药。Poria cocos is sweet, light, and flat in nature. When used as medicine, it has the functions of diuresis and dampness, spleen and stomach, and calming the mind. Modern medical research: Poria cocos can enhance the immune function of the body, and Poria cocos polysaccharide has obvious anti-tumor and liver-protecting effects. Poria cocos is sweet and flat in nature and flavor, and enters the heart, lung and spleen meridians. It has the effects of eliminating dampness and diuresis, invigorating the spleen and stomach, calming the mind and calming the nerves. It can cure dysuria, edema and fullness, phlegm retention and cough, vomiting, nausea, diarrhea, spermatorrhea, stranguria, palpitations, and amnesia. The diuresis of Poria cocos is achieved by invigorating the functions of the spleen and lungs, which is different from other traditional Chinese medicines that directly diuresis. For spleen deficiency diarrhea, taking Poria cocos can not only strengthen the spleen, but also ooze dampness. For diarrhea and leukorrhea caused by spleen deficiency, Poria cocos has the effect of taking care of both specimens and is often compatible with Codonopsis pilosula, Atractylodes macrocephala, and Chinese yam. It can be used as an adjuvant medicine for invigorating the lung and spleen and treating qi deficiency.
五味子温;酸、甘;归肺、心、肾经;收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。《本草经疏》载:五味子主益气者,肺主诸气,酸能收,正入肺补肺,故益气也。其主咳逆上气者,气虚则上壅而不归元,酸以收之,摄气归元,则咳逆上气自除矣。劳伤赢瘦,补不足,强阴,益男子精。《别录》养五脏,除热,生阴中肌者,五味子专补肾,兼补五脏,肾藏精,精盛则阴强,收摄则真气归元,而丹田暖,腐熟水谷,蒸糟粕而化精微,则精自生,精生则阴长,故主如上诸疾也。Schisandra is warm; sour and sweet; returns to the lung, heart, and kidney meridians; astringent and astringent, nourishing qi and promoting body fluid, nourishing the kidney and calming the heart. For chronic cough and shortness of breath, nocturnal spermatorrhea, enuresis, frequent urination, chronic diarrhea, spontaneous sweating, night sweats, thirsty body fluid wounds, shortness of breath and arteries, internal heat and quenching thirst, palpitations and insomnia. "Compendium of Materia Medica" contains: Schisandra governs Qi, the lungs govern all Qi, acid can be absorbed, and it is entering the lungs to nourish the lungs, so it also replenishes Qi. It mainly focuses on those who cough against the upper qi, and if the qi is deficient, the upper qi will be obstructed and not return to the original source. If the acid is absorbed, the qi will be absorbed and returned to the original source, and the cough and upper qi will be eliminated by itself. Lose weight due to overwork, replenish deficiencies, strengthen yin, and benefit men's essence. "Bie Lu" nourishes the five viscera, removes heat, and grows the middle muscles of the yin. When the dross is turned into fine particles, the essence will be self-generated, and when the essence is born, the yin will grow, so it is the same as the above-mentioned diseases.
熟地又名熟地黄或伏地,属玄参科植物,是一种上好中药材,具有补血滋阴功效,可用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症,亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等症,是虚证类非处方药药品六味地黄丸主要成分之一。本品质润入肾,善滋补肾阴,填精益髓,为补肾阴之要药。古人谓之“大补五脏真阴”,“大补真水”。常与山药、山茱萸等同用,治疗肝肾阴虚,腰膝酸软、遗精、盗汗、耳鸣、耳聋及消渴等,可补肝肾,益精髓,如六味地黄丸。Rehmannia glutinosa, also known as Rehmannia glutinosa or Fudi, belongs to the plant of Scrophulariaceae. It is a good Chinese herbal medicine. It has the effect of nourishing blood and nourishing yin. It is one of the main ingredients of Liuwei Dihuang Pills, an over-the-counter drug for deficiency syndromes, which is used for hot flashes, night sweats, nocturnal emission, and thirst due to deficiency of kidney yin. This quality nourishes the kidneys, is good at nourishing kidney yin, replenishes essence and marrow, and is an essential medicine for invigorating kidney yin. The ancients called it "replenishing the five internal organs and true yin" and "replenishing true water". It is often used with yam and dogwood to treat liver and kidney yin deficiency, soreness of the waist and knees, nocturnal emission, night sweats, tinnitus, deafness and thirst, etc. It can nourish the liver and kidney, and benefit the essence, such as Liuwei Dihuang Wan.
黄芪具有补气固表、利水退肿、托毒排脓、生肌等功效。黄芪的药用迄今已有2000多年的历史,现代研究,黄芪含皂甙、蔗糖、多糖、多种氨基酸、叶酸及硒、锌、铜等多种微量元素。有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。但表实邪盛,气滞湿阻,食积停滞,痈疽初起或溃后热毒尚盛等实证。黄芪具有补气固表,利尿托毒,排脓,敛疮生肌的功效。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴。《本经》记载:“主痈疽,久败疮,排脓止痛。补虚,小儿百病。”《日华子本草》记载:“助气壮筋骨,长肉补血。”Astragalus has the effects of invigorating qi and solidifying the surface, diuresis and swelling, detoxification and pus drainage, and muscle regeneration. The medicinal use of Astragalus has a history of more than 2,000 years. Modern research shows that Astragalus contains saponins, sucrose, polysaccharides, various amino acids, folic acid, selenium, zinc, copper and other trace elements. It can enhance the immune function of the body, protect the liver, diuretic, anti-aging, anti-stress, lower blood pressure and have a wide range of antibacterial effects. However, there are evidences such as exuberance of excess pathogens, stagnation of qi and dampness, stagnation of food accumulation, early onset of carbuncle or ulceration of heat and toxin. Radix Astragali has the effects of invigorating qi and strengthening the exterior, diuretic and detoxification, evacuating pus, astringing sores and promoting granulation. For qi deficiency and fatigue, lack of appetite, loose stools, subsidence of central qi, chronic diarrhea and prolapse of the anus, blood in the stool and metrorrhagia, spontaneous perspiration due to superficial deficiency, carbuncle and gangrene that are difficult to ulcerate, chronic ulceration without restraint, blood deficiency and chlorosis, internal heat and quenching thirst. "The Classic" records: "mainly carbuncle and gangrene, long-term sores, draining pus and relieving pain. Tonifies deficiency, and treats all kinds of diseases in children." "Nihuazi Materia Medica" records: "Helps Qi and strengthens muscles and bones, grows flesh and nourishes blood."
制首乌是将生首乌与黑豆同煮后晒干的首乌,是一味补肝肾、益精血、养心宁神的良药。主要用于治疗因肝肾不足、精血亏损而引起的腰膝酸软、头晕眼花、心悸失眠、头发早白等症。何首乌的乌发功能是通过补肾、益精、养血宁神的作用发挥出来的。制首乌具有补益精血,养肝安神,强筋骨,固肾乌须,用于血虚而见头昏目眩,心悸失眠健忘,萎黄乏力,肝肾精血亏虚的眩晕耳鸣,腰膝酸软,遗精崩带,须发早白等症。Radix Polygoni Multiflori is made by boiling raw Radix Polygoni Multiflori with black beans and then drying it in the sun. It is mainly used to treat symptoms such as weakness of the waist and knees, dizziness, palpitations, insomnia, and premature graying of hair caused by deficiency of liver and kidney, and loss of essence and blood. The black hair function of Polygonum multiflorum is exerted through the functions of nourishing the kidney, benefiting the essence, nourishing the blood and calming the mind. Shouwu has the functions of nourishing essence and blood, nourishing the liver and calming the nerves, strengthening the bones and muscles, and strengthening the kidneys. It is used for dizziness and dizziness due to blood deficiency, palpitation, insomnia, forgetfulness, chlorosis and fatigue, dizziness and tinnitus due to liver and kidney essence and blood deficiency, soreness of the waist and knees, Nocturnal emission collapse belt, premature graying of beard and hair embolism.
地骨皮性寒,味甘。功能主治:凉血除蒸,清肺降火。用于阴虚潮热、骨蒸盗汗、肺热咳嗽、咯血、衄血。《别录》:″主风湿,下胸胁气,客热头痛,补内伤大劳嘘吸,坚筋,强阴,利大小肠,耐寒暑。《本草述》:″主治虚劳发热,往来寒热,诸见血证、鼻衄、咳嗽血,咳嗽、喘,消瘅,中风,眩晕,痉痼,腰痛,行痹,脚气,水肿,虚烦,悸,健忘,小便不通,赤白浊。″Digupi is cold in nature and sweet in taste. Functions and indications: cooling blood and removing steam, clearing lung and reducing fire. For yin deficiency hot flashes, bone steaming night sweats, lung heat cough, hemoptysis, epistaxis. "Bie Lu": "mainly rheumatism, lower chest and hypochondrium, heat headache, tonifying internal injuries, breathing, strengthening tendons, strengthening yin, benefiting large and small intestines, cold and heat." Cold and heat, all kinds of blood syndrome, epistaxis, coughing blood, cough, wheezing, diarrhea, stroke, dizziness, convulsions, low back pain, numbness, beriberi, edema, restlessness, palpitations, forgetfulness, difficulty urinating, red and white turbidity. "
白术能显著地增强小肠平滑肌的收缩幅度、收缩频率,延长小肠平滑肌在缺氧情况下的收缩时间,调整胃肠运动功能,具有抗溃疡、保肝和增强机体免疫功能的作用。白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。Atractylodes macrocephala can significantly enhance the contraction amplitude and contraction frequency of small intestinal smooth muscle, prolong the contraction time of small intestinal smooth muscle under hypoxic conditions, adjust gastrointestinal motility function, and have the functions of anti-ulcer, liver protection and enhancing immune function of the body. Atractylodes macrocephala bitter in the mouth, sweet, warm. Return spleen, stomach warp. Cure mainly invigorating the spleen and replenishing qi, drying dampness and diuresis, antiperspirant, antiabortive. For insufficiency of the spleen, lack of food, abdominal distension and diarrhea, dizziness and palpitation due to phlegm and retention, edema, spontaneous sweating, restless fetal movement. Atractylodes macrocephala has cytotoxic effect on tumor cells, can reduce the proliferation rate of tumor cells, reduce the invasiveness of tumor tissues, and improve the body's anti-tumor response ability. "On the Nature of Medicine" contains it: Jun, sweet in the mouth, pungent, nontoxic. Can control strong wind numbness, dysentery due to dysentery for many years, confidant's distending pain, breaks away food, whets the appetite, removes phlegm and salivation, removes cold and heat, and stops diarrhea. The main face is radiant, calms the face, and removes blackness. Control water swelling and fullness, vomiting and nausea, cold pain in the abdomen, vomiting and diarrhea, and cold dysentery due to stomach qi deficiency.
合欢皮性味甘、平。有解郁、和血、宁心、消痈肿之功。有治心神不安、忧郁、失眠、肺痈、痈肿、瘰疠、筋骨折伤之效。《神农本草经》:“合欢,味甘平。主安五脏,利心志,令人欢乐无忧……生山谷。”合欢皮为豆科植物合欢树的皮。夏秋时采剥树皮,晒干药用。性味甘、平。有解郁、和血、宁心、消痈肿之功。有治心神不安、忧郁、失眠、肺痈、痈肿、瘰疠、筋骨折伤之效。Albizia Julibrissin is sweet and flat in nature and flavor. It has the functions of relieving depression, harmonizing blood, calming the heart, and eliminating carbuncle. It has the effect of treating restlessness, depression, insomnia, lung abscess, carbuncle, scrofula, and tendon fracture. "Shen Nong's Materia Medica": "Albizia julibrissin is sweet and flat. It is mainly for the five internal organs, benefiting the heart and mind, making people happy and worry-free... growing valleys." Albizia juniper is the bark of the leguminous plant Albizia julienne tree. In summer and autumn, the bark is peeled and dried for medicinal purposes. Nature and flavor are sweet, flat. It has the functions of relieving depression, harmonizing blood, calming the heart, and eliminating carbuncle. It has the effect of treating restlessness, depression, insomnia, lung abscess, carbuncle, scrofula, and tendon fracture.
覆盆子性温;甘、酸;归肾、膀胱经。主治:益肾,固精,缩尿。用于肾虚遗尿,小便频数,阳痿早泄,遗精滑精。《本草经疏》:″覆盆子,其主益气者,言益精气也。肾藏精、肾纳气,精气充足,则身自轻,发不白也。苏恭主补虚续绝,强阴建阳,悦泽肌肤,安和脏腑。甄权主男子肾精虚竭,阴痿,女子食之有子。大明主安五脏,益颜色,养精气,长发,强志。皆取其益肾添精,甘酸收敛之义耳。″《药性论》载其:″主男子肾精虚竭,女子食之有子。主阴痿。″Raspberry is warm in nature; sweet and sour; returns to kidney and bladder channels. Indications: Tonifying the kidney, strengthening essence, reducing urination. For kidney deficiency enuresis, frequent urination, impotence and premature ejaculation, nocturnal emission and spermatorrhea. "Compendium of Materia Medica": "Raspberry, its main benefit is Qi, and it is also said to benefit essence. Kidney stores essence, kidney receives Qi, and if essence is sufficient, the body will be light and the hair will not be white. Su Gong advocates tonic and continuation Absolutely, strengthens yin and builds yang, brightens the skin, harmonizes viscera. Zhen Quan masters men with kidney deficiency and impotence, and women eat and have children. Great Ming masters the five internal organs, improves color, nourishes essence, grows hair, and strengthens will All take its beneficial kidney to add essence, and the artificial ear of sweet and sour convergence." "On the Nature of Medicine" contains it: "The main man's kidney essence is exhausted, and the woman eats to have children. Main impotence."
淫羊藿,淫羊蕾是中国常用中药,具有很高的药用价值,全草供药用。主治阳萎早泄,腰酸腿痛,四肢麻木,半身不遂,神经衰弱,健忘,耳鸣,目眩等症。Epimedium, epimedium is a commonly used traditional Chinese medicine in China, with high medicinal value, and the whole plant is used for medicinal purposes. Indications for impotence and premature ejaculation, backache and leg pain, numbness of limbs, hemiplegia, neurasthenia, forgetfulness, tinnitus, dizziness and other diseases.
三七甘、微苦,温,归肝、胃经。功效散瘀止血,消肿定痛。主治用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。《本草纲目》:止血散血定痛,金刃箭伤、跌扑杖疮、血出不止者,嚼烂涂,或为末掺之,其血即止。亦主吐血衄血,下血血痢,崩中经水不止,产后恶血不下,血运血痛,赤目痈肿,虎咬蛇伤诸病。《本草求真》:专入肝胃。兼入心大肠。又名山漆。时珍日。或云能合金疮。如漆粘物也。Radix Notoginseng is sweet, slightly bitter, warm, and returns to the Liver and Stomach Meridians. Efficacy dissipating blood stasis to stop bleeding, reducing swelling and relieving pain. Cure mainly for hemoptysis, hematemesis, epistaxis, hematochezia, metrorrhagia, traumatic hemorrhage, chest and abdomen stabbing pain, tumbling and swelling pain. "Compendium of Materia Medica": Stop bleeding, disperse blood and relieve pain, for wounds caused by golden blade arrows, sores caused by falling sticks, and bleeding that does not stop, chew it and apply it, or mix it at the end, and the blood will stop immediately. It also mainly treats hematemesis and epistaxis, bloody dysentery, metrorrhagia, dysmenorrhea, postpartum hemorrhage, pain in blood circulation, red eyes and carbuncle, tiger bites and snake bites. "Materia Medica Seeking Truth": specially enters the liver and stomach. And into the heart and large intestine. Also known as mountain lacquer. Shi Zhenri. Or Yuneng alloy sores. Such as paint stickies also.
枸杞:甘,平。枸杞叶:苦、甘;性凉。功能:枸杞子:养肝,滋肾,润肺。枸杞叶:补虚益精,清热明目。枸杞多糖是一种水溶性多糖,是枸杞中最主要的活性成分,相对分子质量为68-200,成为国内外研究热点。其中又以枸杞多糖的免疫调节和抗肿瘤作用的研究最多。现已有很多研究表明枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。Lycium barbarum: sweet, flat. Lycium barbarum leaves: bitter, sweet; cool in nature. Function: Lycium barbarum: nourishes the liver, nourishes the kidney, moistens the lungs. Lycium barbarum leaves: tonifies deficiency and essence, clears away heat and improves eyesight. Lycium barbarum polysaccharide is a water-soluble polysaccharide, which is the most important active ingredient in Lycium barbarum, with a relative molecular mass of 68-200, and has become a research hotspot at home and abroad. Among them, the immune regulation and anti-tumor effects of Lycium barbarum polysaccharides are the most studied. Many studies have shown that Lycium barbarum polysaccharide has the functions of promoting immunity, anti-aging, anti-tumor, scavenging free radicals, anti-fatigue, anti-radiation, protecting liver, protecting and improving reproductive functions, etc.
绞股蓝,又称:天堂草、福音草、超人参、公罗锅底、遍地生根、七叶胆、五叶参和七叶参等,拉丁文名:Gynostemmapentaphyllum(Thunb.)Makino葫芦科、绞股蓝属草质攀援植物;茎细弱,具分枝,具纵棱及槽,无毛或疏被短柔毛,生长在南方的绞股蓝药用含量比较高,民间称其为神奇的“不老长寿药草”,绞股蓝主要有效成份是绞股蓝皂甙、绞股蓝糖甙(多糖)、水溶性氨基酸、黄酮类、多种维生素、微量元素、矿物质等。作用功效:降血脂,调血压防治血栓,防治心血管疾患,调节血糖,促睡眠,缓衰老,防抗癌,提高免疫力,调节人体生理机能。绞股蓝能保护肾上腺和胸腺及内分泌器官随年龄的增长而不致萎缩,维持内分泌系统的机能,并具有降血糖和改善糖代谢作用。Gynostemma, also known as: Paradise Grass, Gospel Grass, Super Ginseng, Gong Luo Pan Bottom, Rooting Everywhere, Aescin, Five-leaf Ginseng and Aescin, etc., Latin name: Gynostemmapentaphyllum (Thunb.) Makino Cucurbitaceae, Gynostemma genus Quality climbing plants; stems are thin and weak, with branches, longitudinal ribs and grooves, glabrous or sparsely pubescent, and the medicinal content of Gynostemma pentaphylla growing in the south is relatively high. Folks call it the magical "herb of longevity and longevity". The main active ingredients are gypenoside, gypenoside (polysaccharide), water-soluble amino acid, flavonoids, multivitamins, trace elements, minerals, etc. Efficacy: lowering blood fat, regulating blood pressure, preventing thrombosis, preventing and treating cardiovascular diseases, regulating blood sugar, promoting sleep, delaying aging, preventing and anti-cancer, improving immunity, and regulating human physiological functions. Gynostemma can protect the adrenal gland, thymus gland and endocrine organs from atrophy with age, maintain the function of the endocrine system, and have the effect of lowering blood sugar and improving glucose metabolism.
红景天(学名:Rhodiola rosea L.),别名:蔷薇红景天,扫罗玛布尔(藏名)等;为多年生草本植物,高10-20厘米。根粗壮,圆锥形,肉质,褐黄色,根颈部具多数须根,根茎短,粗状,圆柱形,被多数覆瓦状排列的鳞片状的叶。生长在海拔1800-2500米高寒无污染地带,其生长环境恶劣,因而具有很强的生命力和特殊的适应性。可作药用,能够补气清肺,益智养心,是一味作用广泛的中药。亦有很大的美容效果,可作护肤品,也可食用。性味:寒、甘、涩。归经:肺经。功能主治:有补气清肺、益智养心、收涩止血、散瘀消肿的功效。主治气虚体弱、病后畏寒、气短乏力、肺热咳嗽、咯血、白带腹泻、跌打损伤等。中国古代第一部医学典籍《神农本草经》,将红景天列为药中上品,服用红景天轻身益气,不老延年,无毒多服,久服不伤人。能补肾,理气养血,主治周身乏力、胸闷等;还具有活血止血、清肺止咳、解热,并止带下的功效。Rhodiola rosea (scientific name: Rhodiola rosea L.), alias: Rhodiola rosea, Saul Marble (Tibetan name), etc.; it is a perennial herb, 10-20 cm high. The root is thick, conical, fleshy, brownish yellow, with many fibrous roots at the root neck, the rhizome is short, thick, cylindrical, covered by many scale-like leaves arranged in tiles. It grows in the alpine and pollution-free zone at an altitude of 1800-2500 meters, and its growth environment is harsh, so it has strong vitality and special adaptability. It can be used as medicine, can invigorate qi and clear the lungs, improve intelligence and nourish the heart, and is a traditional Chinese medicine with a wide range of effects. It also has a great cosmetic effect and can be used as a skin care product or edible. Nature and flavor: cold, sweet, astringent. Meridian return: lung meridian. Functions and Indications: It has the effects of invigorating qi and clearing the lungs, improving intelligence and nourishing the heart, reducing astringency to stop bleeding, dispelling blood stasis and reducing swelling. It is mainly used to treat qi deficiency and frailty, chills after illness, shortness of breath and fatigue, cough due to lung heat, hemoptysis, leucorrhea diarrhea, bruises, etc. The first medical classic in ancient China, "Shen Nong's Materia Medica", listed Rhodiola as a top-grade medicine. Taking Rhodiola can lighten the body and nourish Qi, prevent aging and prolong life. It can invigorate the kidney, regulate qi and nourish blood, and treat general fatigue and chest tightness. It also has the effects of promoting blood circulation to stop bleeding, clearing lung and relieving cough, antipyretic, and stopping leukorrhea.
桑葚滋阴养血药;生津药;润肠药。补血滋阴,生津润燥。用于眩晕耳鸣,心悸失眠,须发早白,津伤口渴,内热消渴,血虚便秘。补肝,益肾,熄风,滋液。治肝肾阴亏,消渴,便秘,目暗,耳鸣,瘰疬,关节不利。既可入食,又可入药,中医认为桑葚味甘酸,性微寒,入心、肝、肾经,为滋补强壮、养心益智佳果。具有补血滋阴,生津止渴,润肠燥等功效,主治阴血不足而致的头晕目眩,耳鸣心悸,烦躁失眠,腰膝酸软,须发早白,消渴口干,大便干结等症。Mulberry nourishes yin and nourishes blood; promotes body fluid; moistens intestines. Enriches blood and nourishes yin, promotes fluid production and moisturizes dryness. For vertigo and tinnitus, palpitation and insomnia, premature graying of beard and hair, thirsty wounds, internal heat quenching one's thirst, blood deficiency and constipation. Invigorate the liver, nourish the kidney, quench the wind, and nourish the liquid. Treat liver and kidney yin deficiency, diabetes, constipation, dark eyes, tinnitus, scrofula, and joint discomfort. It can be eaten or used as medicine. Chinese medicine believes that mulberries are sweet and sour in taste and slightly cold in nature. They enter the heart, liver, and kidney meridians. It has the effects of nourishing blood and nourishing yin, promoting body fluid to quench thirst, moistening intestines and dryness, etc. It is mainly used to treat dizziness, tinnitus and palpitations, irritability and insomnia, soreness of waist and knees, premature graying of beard and hair, thirst and dry mouth, dry stool and other symptoms caused by deficiency of yin and blood.
小米草,学名:Euphrasia pectinata Ten,为一年生草本植物,全草具药用价值。味苦;性微寒,归膀胱经,功能主治清热解毒;利尿。主热病口渴;头痛;肺热咳嗽;咽喉肿痛;热淋;小便不利;口疮;痈肿。Eyebright, scientific name: Euphrasia pectinata Ten, is an annual herb, and the whole plant has medicinal value. Bitter in the mouth; slightly cold in nature, returns bladder meridian, function cures mainly heat-clearing and toxic substances removing; Diuresis. Mainly fever and thirst; headache; lung heat cough; sore throat; hot stranguria; dysuria; aphtha; carbuncle.
山药又称薯蓣、土薯、山薯蓣、怀山药、淮山、白山药,是《中华本草》收载的草药,药用来源为薯蓣科植物山药干燥根茎。山药具有滋养强壮,助消化,敛虚汗,止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎。山药最适宜与灵芝搭配服用,具有防治糖尿病的作用,山药在食品业和加工业上大有发展前途。Yam, also known as yam, native potato, yam, Huai yam, Huaishan, and white yam, is a herbal medicine recorded in "Chinese Materia Medica", and its medicinal source is the dried rhizome of yam, a plant of the family Dioscoreae. Yam has the functions of nourishing and strengthening, aiding digestion, suppressing sweating due to deficiency, and stopping diarrhea. Yam is most suitable to be taken with Ganoderma lucidum, which has the effect of preventing and treating diabetes. Yam has great development prospects in the food industry and processing industry.
赤芍,中药名。为毛茛科植物赤芍或川赤芍的干燥根。春、秋二季采挖,除去根茎、须根及泥沙,晒干。苦,微寒。归肝经。有清热凉血,活血祛瘀的功效。《神农本草经》:“芍药,味苦平。主邪气腹痛,除血痹、破坚积寒热疝瘕、止痛......生川谷。”《名医别录》:“芍药生中岳川谷及丘陵,二月、八月采根暴干。”Radix Paeoniae Rubra, the name of traditional Chinese medicine. It is the dry root of Radix Paeoniae Rubra or Radix Radix Radix Paeoniae Rubra of Ranunculaceae. Excavated in spring and autumn, removed rhizomes, fibrous roots and sediment, and dried in the sun. Bitter, slightly cold. Return liver channel. It has the effects of clearing heat and cooling blood, promoting blood circulation and removing blood stasis. "Shennong Materia Medica": "Peony, bitterness and flatness. Lord evil qi and abdominal pain, removing blood paralysis, breaking the cold and heat hernia, relieving pain ... Shengchuan Valley." "Famous Doctor" And hills, harvest roots and dry out in February and August."
牛膝根入药,生用,活血通经;治产后腹痛,月经不调,闭经,鼻衄,虚火牙痛,脚气水肿;熟用,补肝肾,强腰膝;治腰膝酸痛,肝肾亏虚,跌打瘀痛。兽医用作治牛软脚症,跌伤断骨等。入药部位:植物的干燥根。性味:苦、甘、酸,平。归经:归肝、肾经。功效:逐瘀通经,补肝肾,强筋骨,利尿通淋,引血下行。主治:用于经闭,痛经,腰膝酸痛,筋骨无力,淋证,水肿,头痛,眩晕,牙痛,日疮,吐血,衄血。Achyranthes bidentata root is used as medicine, used raw, promoting blood circulation and promoting menstruation; treating postpartum abdominal pain, irregular menstruation, amenorrhea, epistaxis, toothache due to deficiency fire, beriberi edema; cooked use, nourishing liver and kidney, strengthening waist and knees; treating soreness of waist and knees, liver and kidney deficiency Deficiency, bruises and bruises. Veterinarians use it to treat bovine soft feet, falls and broken bones. Medicinal part: the dry root of the plant. Nature and flavor: bitter, sweet, sour, flat. Return through: return liver, kidney channel. Efficacy: expel blood stasis to stimulate menstrual flow, nourish liver and kidney, strengthen muscles and bones, diuresis and relieve stranguria, induce blood to descend. Indications: For amenorrhea, dysmenorrhea, soreness of the waist and knees, weakness of muscles and bones, stranguria, edema, headache, dizziness, toothache, sun sore, vomiting blood, epistaxis.
延胡索辛;苦;温;无毒,归经:肝;胃;心;肺;脾经。主治:活血;散瘀;理气;止痛。主心腹腰膝诸痛;月经不调;症瘕;崩中;产后血晕;恶露不尽;跌打损伤。《雷公炮炙论》:治心痛欲死。《日华子本草》:除风,治气,暖腰膝,破症癖,扑损瘀血,落胎,及暴腰痛。《开宝本草》:主破血,产后诸病,因血所为者。妇人月经不调,腹中结块,崩中淋露,产后血运,暴血冲上,因损下血,或酒摩及煮服。Corydalis pungent; bitter; warm; nontoxic, meridian distribution: liver; stomach; heart; lung; spleen meridian. Indications: promoting blood circulation; dispelling blood stasis; regulating qi; relieving pain. Main confidant waist and knee pain; irregular menstruation; lump in the abdomen; metrorrhagia; postpartum haemorrhage; lochia endlessly; bruises. "Lei Gong Pao Shao Lun": cure heartache. "Nihuazi Materia Medica": eliminates wind, controls qi, warms the waist and knees, breaks symptoms, beats damage and blood stasis, abortion, and sudden lumbago. "Kaibao Materia Medica": Mainly breaks blood, and postpartum diseases are caused by blood. Irregular menstruation in women, lumps in the abdomen, metrorrhagia, postpartum blood circulation, rush of blood, bleeding due to damage, or rubbed with alcohol or boiled.
金银花,又名忍冬(学名:Lonicera japonica)。“金银花”一名出自《本草纲目》,由于忍冬花初开为白色,后转为黄色,因此得名金银花。药材金银花为忍冬科忍冬属植物忍冬及同属植物干燥花蕾或带初开的花。金银花自古被誉为清热解毒的良药。它性甘寒气芳香,甘寒清热而不伤胃,芳香透达又可祛邪。金银花既能宣散风热,还善清解血毒,用于各种热性病,如身热、发疹、发斑、热毒疮痈、咽喉肿痛等症,均效果显著。Honeysuckle, also known as honeysuckle (scientific name: Lonicera japonica). The name "Honeysuckle" comes from "Compendium of Materia Medica". Because the honeysuckle flower is white at first, and then turns yellow, it is named honeysuckle. The medicinal material honeysuckle is the dried flower buds or flowers of the same genus Lonicera Lonicera and the same genus. Honeysuckle has been known as a good medicine for clearing away heat and detoxification since ancient times. It is sweet and cold in nature and fragrant, sweet and cold to clear away heat without hurting the stomach, and the fragrance is thorough and can dispel evil. Honeysuckle can not only disperse wind-heat, but also clear blood toxin. It is used for various febrile diseases, such as body heat, rash, spots, heat-toxin sores, sore throat, etc., and the effect is remarkable.
具体实施例1:Specific embodiment 1:
先将仙茅萃取。The curculigo is extracted first.
再将其余原料地骨皮,白术,熟地,红景天,淫羊藿,三七,黄芪,绞股蓝,五味子,合欢皮,覆盆子,茯苓,制首乌,桑葚,枸杞,小米草,山药,牛膝,赤芍,延胡索,金银花,提取浓缩制成颗粒剂、粉剂或膏剂。Then use the other raw materials Digupi, Atractylodes macrocephala, Rehmannia glutinosa, Rhodiola rosea, Epimedium, Panax notoginseng, Astragalus, Jiaogulan, Schisandra chinensis, Albizia juniper, raspberry, Poria cocos, Zhishouwu, mulberry, wolfberry, eyebright, yam, Achyranthes bidentata, Radix Paeoniae Rubra, Corydalis Corydalis, Honeysuckle, extracted and concentrated to make granule, powder or ointment.
制备好的山茱萸与其他原料的提取物颗粒剂,紫外线杀菌消毒装袋,使用时直接可以用开水冲服。The prepared extract granules of Cornus officinalis and other raw materials are sterilized by ultraviolet rays and packed in bags, and can be directly washed with boiled water when used.
具体实施例2:Specific embodiment 2:
将采集的仙茅大约5000g,切碎,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用,作为组分1。About 5000g of curculigo collected, chopped, soaked and placed in a stainless steel bucket with a cover, added 70% ethanol solution, the mass is 0.8-1 times of coarse particles, stirred evenly, kept moist and airtight for more than 1 hour, so that fully Expansion: Wrap the filter plate at the bottom of the percolation cylinder with a gauze bag and pave it flat, then mix and loosen the wet and expanded drug samples, then use a stainless steel spoon to fill the powder, and put it evenly into the percolation cylinder, with a thickness of 10-12 cm , press evenly with a T-shaped rod, and then follow the above operation, load layer by layer, pressurize appropriately, the powder filling should not exceed 2/3 of the height of the percolation cylinder; the powder surface is covered with a stainless steel orifice plate and pressed firmly, Open the discharge valve under the percolation cylinder, put a container, and then slowly add 70% ethanol liquid; after the air between the powder particles is discharged, and about 20L of ethanol flows out, close the discharge valve and cover the filter After soaking for 24 hours, open the material valve for percolation, control the percolation speed, generally 1000g of medicinal materials flow out 2-3ml per minute, put the filtrate into the liquid storage tank, and pour the ethanol solution when emptying into the liquid storage tank ; Combine the leachate and let it stand for later use as component 1.
将剩余原料地骨皮1500g,白术1500g,熟地1500g,红景天1500g,淫羊藿1500g,三七1500g,黄芪1500g,绞股蓝1500g,五味子1500g,合欢皮1500g,覆盆子1500g,茯苓1500g,制首乌1500g,桑葚1500g,枸杞1500g,小米草1500g,山药1500g,牛膝1500g,赤芍1500g,延胡索1500g,金银花1500g洗净去杂,泡入乙醇,加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,作为组分2。The remaining raw materials are 1500g Digupi, 1500g Atractylodes macrocephala, 1500g Rehmannia glutinosa, 1500g Rhodiola, 1500g Epimedium, 1500g Sanqi, 1500g Astragalus, 1500g Jiaogulan, 1500g Schisandra, 1500g Albizia Jubilata, 1500g raspberry, 1500g Poria cocos. 1500g blackberry, 1500g mulberry, 1500g wolfberry, 1500g eyebright, 1500g yam, 1500g achyranthes bidentata, 1500g red peony root, 1500g corydalis corydalis, 1500g honeysuckle flower, washed to remove impurities, soaked in ethanol, heated and refluxed twice, 1 to 2 hours each time , combine the two extracts and let stand; combine the above two extracts, recover ethanol under reduced pressure and concentrate until the concentration of the medicinal solution is 0.6g crude drug/mL, after suction filtration, the relative density of the filtrate is about 1.08 at 20°C; Reduce the pressure to 0.03-0.08MPa, keep the temperature at 60-80°C, concentrate to a relative density of 1.20, and extract the extract at a temperature of 60°C-70°C as component 2.
将组分1与组分2置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,然后加糊精制成口服液。Put components 1 and 2 into a double-effect vacuum concentrator, concentrate to a concentrated solution with a relative density of 1.05 at 90°C, and refrigerate at a low temperature of 0-5°C for 24 hours; add 0.3% filter aid to the refrigerated solution Diatomaceous earth, filter, and put the filtrate into a double-effect vacuum concentrator, concentrate to contain 0.1g of crude drug per 1ml, and then add dextrin to make an oral liquid.
具体实施例3:Specific embodiment 3:
采集的仙茅大约4000g,切碎,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用,作为组分1;将剩余原料地骨皮1200g,白术1200g,熟地1300g,红景天1200g,淫羊藿1300g,三七1200g,黄芪1100g,绞股蓝1100g,五味子1200g,合欢皮1100g,覆盆子1200g,茯苓1300g,制首乌1200g,桑葚1200g,枸杞1200g,小米草1200g,山药1200g,牛膝1200g,赤芍1100g,延胡索1100g,金银花1200g,将其放入10倍量水中浸泡。投入多功能提取罐提取两次,第一次加8-10倍量水煎煮1-2小时,第二次加4-8倍量水煎煮1-2小时,合并两次煎液,过滤得滤液;加热浓缩至膏状,加蜂蜜调和制剂。About 4000g of curculigo collected, chopped, soaked in a stainless steel bucket with a cover, added 70% ethanol solution, the mass is 0.8-1 times that of coarse particles, stirred evenly, kept moist and airtight for more than 1 hour, so that it can fully expand Wrap the filter plate at the bottom of the percolation cylinder with a gauze bag and spread it flat, then mix and loosen the wet and swelled drug sample, then use a stainless steel spoon to fill the powder, and put it evenly into the percolation cylinder, with a thickness of 10-12 cm. Use a T-shaped rod to press evenly, and then follow the above operation, load layer by layer, pressurize appropriately, the powder filling should not exceed 2/3 of the height of the percolation cylinder; the surface of the powder is covered with a stainless steel orifice plate, press firmly, open Put the discharge valve under the percolation cylinder, and put a container, and then slowly add 70% ethanol liquid; after the air between the powder particles is discharged, and about 20L of ethanol flows out, close the discharge valve and cover the cylinder , Immerse for 24 hours, then open the material valve for percolation, control the percolation speed, generally 1000g medicinal materials flow out 2-3ml per minute, put the filtrate into the liquid storage tank, and pour the ethanol liquid when emptying into the liquid storage tank; Combine the leachate and let it stand for later use as component 1; the remaining raw materials Digupi 1200g, Atractylodes macrocephala 1200g, Rehmannia glutinosa 1300g, Rhodiola rosea 1200g, Epimedium 1300g, Panax notoginseng 1200g, Astragalus 1100g, Jiaogulan 1100g, 1200g schisandra, 1100g acacia, 1200g raspberry, 1300g poria cocos, 1200g mulberry, 1200g wolfberry, 1200g eyebright, 1200g yam, 1200g achyranthes, 1100g red peony, 1100g corydalis, 1200g honeysuckle, put them in Soak in 10 times the amount of water. Put it into a multi-functional extraction tank to extract twice, add 8-10 times the amount of water to decoct for 1-2 hours for the first time, add 4-8 times the amount of water to decoct for 1-2 hours for the second time, combine the two decoctions, and filter Obtain filtrate; heat and concentrate to paste, add honey to reconcile the preparation.
药理学毒性试验Pharmacological toxicity test
实验例1:本发明急性毒性试验Experimental example 1: acute toxicity test of the present invention
一、试验材料:动物:昆明种小鼠,体重18-25g,雌雄各半,山东大学生物试验室育种。药物:本发明(所有原材料混合煎煮2次,合并过滤,取药液)含0.0365mg/ml。1. Test materials: Animals: Kunming mice, weighing 18-25g, half male and half male, bred by the biological laboratory of Shandong University. Medicine: the present invention (all raw materials are mixed and decocted twice, combined and filtered, and the medicinal solution is taken) contains 0.0365 mg/ml.
二、方法:2. Method:
1、LD50计算:采用改良寇氏法,将小鼠随机分成5组,每组10只,雌雄各半,将本发明加蒸馏水溶解,配成最大浓度,按小鼠最大允许容量给药,所给剂量按生药量依次为18,14.4,11.5,9.2,7.4(g.kg-1),在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml,观察动物死亡情况。1. Calculation of LD50: adopt the modified Cole's method, mice are randomly divided into 5 groups, 10 in every group, half male and half male, the present invention is dissolved in distilled water, made into maximum concentration, and administered according to the maximum allowable capacity of mice. Dosing is followed by 18, 14.4, 11.5, 9.2, 7.4 (g.kg-1) according to the crude drug amount, and after the animal is fasted (can't help water) for 18 hours, it is divided into two administrations (interval half an hour) in one day, 0.5ml each time, observe the animal death.
2、最大耐受剂量测定(MTD值):取小鼠20只,雌雄各10只。将本发明加蒸馏水溶解,配成最高浓度,按动物的最大耐受量,以注射灌喂器能抽动为准。在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml(每ml含生药0.36g),总药量为18g生药/kg.d,相当临床成人50Kg体重用量的300倍。给药后连续观察7天。2. Determination of maximum tolerated dose (MTD value): take 20 mice, 10 males and 10 males. The present invention is added with distilled water and dissolved to make the highest concentration. According to the maximum tolerance of the animal, the injection feeding device can twitch as the criterion. After the animals fasted (without water) for 18 hours, they were administered twice a day (with an interval of half an hour), 0.5ml each time (each ml contained 0.36g of crude drug), and the total drug dose was 18g of crude drug/kg.d, equivalent to 300 times the amount of clinical adult 50Kg body weight. Continuous observation for 7 days after administration.
三、试验结果:3. Test results:
在LD50计算中当用最大允许浓度和最大允许容量给予小鼠时(18g/Kg.d),未见小鼠死亡,即未测出LD50,只可求最大耐受剂量,在7天观察期中,动物其食欲、活动、毛色、精神状态等皆正常,发育正常,未见有死亡。即选用相当于临床剂量的300倍药量,并无不良反应发生,表明急性毒性极小,MTD>18g/Kg.d。In the LD50 calculation, when the mice were administered with the maximum allowable concentration and the maximum allowable capacity (18g/Kg.d), no death of the mice was seen, that is, the LD50 was not measured, and only the maximum tolerated dose could be obtained. During the 7-day observation period , the animals' appetite, activity, coat color, mental state, etc. were all normal, and the development was normal, and no death was seen. That is, the dosage equivalent to 300 times of the clinical dose was selected, and no adverse reaction occurred, indicating that the acute toxicity was extremely small, and the MTD was greater than 18g/Kg.d.
实验例2:急性毒性及长期毒性的试验结果Experimental example 2: Acute toxicity and long-term toxicity test results
急性毒性试验:通过小白鼠一次性灌胃给予本发明,最高浓度35%,最大灌胃容量0.4ml/10g,剂量14g/kg(每g药粉相当于10g生药),连续观察7天,未发现任何毒性反应,因浓度和剂量无法增加,故未能测出该药的LD 50。最大耐受量测定:以最高浓度,最大灌胃容量,小白鼠灌胃给药3次,间隔5小时,然后连续观察7天,无一例死亡。药粉剂量为>42g/kg.日(每g药粉相当于10g生药),按公斤体重计算相当于成人临床日用量的420倍。Acute toxicity test: give the present invention by one-time gavage of mice, maximum concentration 35%, maximum gavage capacity 0.4ml/10g, dose 14g/kg (every g of powder is equivalent to 10g crude drug), observe continuously for 7 days, no For any toxic reaction, the LD 50 of the drug could not be measured because the concentration and dose could not be increased. Determination of the maximum tolerated dose: with the highest concentration and the maximum gavage volume, the mice were gavaged three times with an interval of 5 hours, and then observed continuously for 7 days, and no case died. The dosage of the medicinal powder is >42g/kg.day (each g of medicinal powder is equivalent to 10g of crude drug), which is equivalent to 420 times of the clinical daily dosage of an adult in terms of kilogram body weight.
长期毒性试验:为观察长期用药是否产生毒性反应,分别给予大鼠本发明饲服,按成人临床日用量的70倍和35倍(即7g/kg/日和3.5g/kg/日),连续给喂8周,未见大鼠的行为、进食、体重出现异常,与对照组比,血常规,肝肾功能,各种重要脏器均无异常改变,在所用药剂量范围内,未曾发现本发明的任何毒副反应。通过动物的急慢性毒性试验证实,本发明安全范围较大,是一种安全可靠的保健品。Long-term toxicity test: in order to observe whether long-term medication produces toxic reactions, give rats the present invention to feed respectively, by 70 times and 35 times (being 7g/kg/ day and 3.5g/kg/ day) of adult's clinical daily dose, continuous After feeding for 8 weeks, there was no abnormality in the behavior, eating, and body weight of the rats. Compared with the control group, the blood routine, liver and kidney functions, and various important organs had no abnormal changes. Any toxic and side effects of the invention. Acute and chronic toxicity tests on animals prove that the invention has a large safety range and is a safe and reliable health care product.
药效学实验:Pharmacodynamics experiment:
用现代免疫学理论和技术,研究中药对增强与调节机体免疫功能的作用,这对阐明有关中医理论的物质基础有着十分重要的意义。本发明由山茱萸、党参、黄芪等数种天然药物经科学配伍而成。已有的研究发现,山茱萸可调整机体各系统脏器的功能,对免疫细胞和免疫分子均有调节作用。本实验旨在进一步探讨本发明对免疫力低下小鼠免疫调节作用的分子免疫学机制。Using modern immunology theory and technology to study the effect of traditional Chinese medicine on enhancing and regulating the immune function of the body is of great significance for clarifying the material basis of the theory of traditional Chinese medicine. The invention is formed by scientific compatibility of several natural medicines such as cornel officinalis, codonopsis pilosula and astragalus. Existing studies have found that Cornus officinalis can adjust the functions of various organs of the body, and has a regulatory effect on immune cells and immune molecules. This experiment aims to further explore the molecular immunological mechanism of the present invention's immunoregulatory effect on immunocompromised mice.
1材料与方法1 Materials and methods
1.1仪器与试剂:本发明仙茅口服液由本院提供(按实施例2方法制备);注射用环磷酰胺由上海华联制药有限公司提供。细胞因子检测试剂盒均购于美国R&D公司。流式细胞仪,2000FCA,美国BD公司生产。1.1 Instruments and reagents: Curculigo curculigo Oral Liquid of the present invention is provided by the hospital (prepared according to the method in Example 2); cyclophosphamide for injection is provided by Shanghai Hualian Pharmaceutical Co., Ltd. Cytokine detection kits were purchased from American R&D Company. Flow cytometer, 2000FCA, produced by BD Company of the United States.
1.2动物昆明系雄性小鼠30只,5-7周,体重为25±2g,由山东大学实验动物有限责任公司提供。1.2 Animals Thirty Kunming male mice, 5-7 weeks old, weighing 25±2g, were provided by Shandong University Experimental Animal Co., Ltd.
1.3方法1.3 Method
1.3.1动物模型建立与分组将昆明系雄性小鼠随机分为3组:空白对照组、模型组和药物组,每组10只。空白对照组:实验进程中正常饲养不作任何处理;模型组:腹腔内注射100mg/kg环磷酰胺造成免疫力低下模型,1次/d,连续3天;药物组:腹腔内注射100mg/kg环磷酰胺造成免疫力低下模型,1次/d,连续3天,并在造模第一天在小鼠左胫前肌涂抹给药,0.1mL/只,一周后加强免疫1次,剂量同第一次。4d后采集样本。1.3.1 Establishment of animal model and grouping Kunming male mice were randomly divided into 3 groups: blank control group, model group and drug group, with 10 mice in each group. Blank control group: normal feeding without any treatment during the experiment; model group: intraperitoneal injection of 100 mg/kg cyclophosphamide to cause hypoimmunity model, once a day, for 3 consecutive days; drug group: intraperitoneal injection of 100 mg/kg cyclophosphamide Phosphoramide induced hypoimmunity model, 1 time/d, for 3 consecutive days, and smeared on the left tibialis anterior muscle of mice on the first day of modeling, 0.1mL/mouse, boosted immunization once a week later, the dose was the same as that of the first day once. Samples were collected after 4 days.
1.3.2小鼠免疫器官指数的测定小鼠称量体重后,颈椎脱臼处死小鼠,取胸腺、脾脏称其湿重,计算胸腺指数和脾指数:胸腺指数=胸腺重×1000/体重脾指数=脾重×1000/体重1.3.3小鼠血清IgG,IgM水平的测定按试剂盒说明书方法,测定小鼠血清中IgG,IgM含量。1.3.2 Determination of immune organ index in mice After the mice were weighed, the mice were killed by cervical dislocation, and the thymus and spleen were taken to weigh their wet weight, and the thymus index and spleen index were calculated: thymus index=thymus weight×1000/body weight and spleen index =spleen weight×1000/body weight 1.3.3 Determination of IgG and IgM levels in mouse serum According to the kit instructions, the IgG and IgM levels in mouse serum were measured.
1.3.4小鼠脾组织T淋巴细胞及其亚群CD4+,CD8+及CD4+/CD8+的测定无菌取脾,置于盛有适量无Hank’s液平皿中,用镊子轻轻将脾磨碎,制成单个胞悬液,经200目筛网过滤,将细胞悬浮于1mL的完全培养液中,调整细胞浓度1×109L-1,用微量移液器小心地将100μL充分混匀的脾细胞悬液加到进样管的底部,加20μL单克隆抗体,低速振荡混匀3S,室温避光孵育30min,于The medicine studyPREP破碎红细胞后,上流式细胞仪检测T细胞亚群含量。1.3.4 Determination of T lymphocytes and their subsets CD4+, CD8+ and CD4+/CD8+ in mouse spleen tissue Aseptically take the spleen, place it in a plate containing an appropriate amount of Hank's-free liquid, and gently grind the spleen with tweezers to prepare A single cell suspension was filtered through a 200-mesh sieve, the cells were suspended in 1 mL of complete culture medium, and the cell concentration was adjusted to 1×10 9 L -1 , and 100 μL of well-mixed splenocytes were carefully suspended with a micropipette. Add the solution to the bottom of the injection tube, add 20 μL of monoclonal antibody, oscillate at low speed for 3 seconds, incubate at room temperature in the dark for 30 minutes, break red blood cells in The medicine studyPREP, and detect the content of T cell subsets on a flow cytometer.
1.3.5小鼠血清IFN-Y、IL-10水平的测定按试剂盒说明书方法,测定血清中IFN-Y、IL-10的水平。1.3.5 Determination of IFN-Y and IL-10 levels in mouse serum According to the kit instructions, the levels of IFN-Y and IL-10 in serum were measured.
1.2统计学处理所有数值均以x±s表示,运用SPSS13.0统计软件进行数据分析,组间比较采用t检验。以P<0.05作为统计显著性差异标准。1.2 Statistical processing All values are represented by x ± s, and SPSS13.0 statistical software is used for data analysis, and t test is used for comparison between groups. Take P<0.05 as the standard of statistically significant difference.
2结果2 results
2.1对免疫力低下小鼠免疫器官的影响由表1得出,与正常对照组相比,模型组脾脏和胸腺指数显著降低,差异有统计学意义,P<0.01。与模型组比较,药物组小鼠脾脏指数明显增加,具有统计学意义,P<0.01,胸腺指数也有所增加,但差异不显著。2.1 Effects on the immune organs of the immunocompromised mice It can be concluded from Table 1 that compared with the normal control group, the spleen and thymus indexes in the model group were significantly lower, and the difference was statistically significant, P<0.01. Compared with the model group, the spleen index of the mice in the drug group increased significantly, which was statistically significant, P<0.01, and the thymus index also increased, but the difference was not significant.
表1本发明对免疫力低下小鼠免疫器官重量的的影响(n=10,mean±s)Table 1 The present invention is to the influence (n=10, mean ± s) of immunocompromised mice immune organ weight
与正常对照组比:△:P<0.05,△△:P<0.01;与模型组比:*:P<0.05,**:P<0.01Compared with the normal control group: △: P<0.05, △△: P<0.01; compared with the model group: *: P<0.05, **: P<0.01
2.2对免疫力低下小鼠脾组织T淋巴亚群的影响由表2看出,与正常对照组相比,模型组小鼠脾脏CD4+细胞亚群百分比下降,CD8+细胞亚群百分比上升,具有显著差异,P<0.05,CD4+/CD8+比值明显降低,具有极显著性差异,P<0.01。而药物组能明显抵消环磷酰胺破坏免疫力的作用,具有显著性差异,P<0.05。2.2 Effects on T lymphoid subgroups in spleen tissue of immunocompromised mice It can be seen from Table 2 that compared with the normal control group, the percentage of CD4+ cell subsets in the spleen of the model group mice decreased, and the percentage of CD8+ cell subsets increased, with significant differences , P<0.05, the ratio of CD4+/CD8+ decreased significantly, with a very significant difference, P<0.01. However, the drug group can obviously counteract the effect of cyclophosphamide on destroying immunity, with a significant difference, P<0.05.
表2金刚天盾液对免疫力低下小鼠体液T细胞亚群的的影响(n=10,mean±SD)Table 2 The effect of King Kong Tiandun Liquid on humoral T cell subsets in immunocompromised mice (n=10, mean±SD)
与正常对照组比:△P<0.05,△△p<0.05;与比模型组:*P<0.05,**P<0.05。Compared with the normal control group: △P<0.05, △△p<0.05; compared with the model group: *P<0.05, **P<0.05.
胸腺、脾脏为机体的重要淋巴器官。胸腺是T细胞发育,分化,成熟的场地,其结构及功能与机体状态紧密相关。胸腺指数的降低以及胸腺萎缩,都是小鼠以细胞免疫为主的免疫抑制的表现。脾脏是体内最大的外周免疫器官,脾脏的免疫细胞以B淋巴细胞为主,而B淋巴细胞是参与体液免疫的主要细胞,因此脾脏与机体体液免疫的关系密切。胸腺指数和脾指数直观的反应了免疫机体功能的强弱。本实验表明,本发明对环磷酰胺所致免疫力低下小鼠脾脏的发育有促进作用,对胸腺的发育也有一定的促进作用。T淋巴细胞按其功能可分为CD4+和CD8+两个亚群。CD4+T淋巴细胞在机体的免疫反应中处于非常重要的中心地位,它通过分泌多种淋巴因子激活其他T、B细胞亚群及参与免疫反应的其他细胞,使其增殖和分化,并协调免疫细胞间的相互作用,发挥机体免疫系统的功能。CD4+/CD8+的比值上升,提示免疫应答的正调节占优势,而比值下降,提示免疫功能低下。对外周血中T淋巴细胞亚群的测定,表明本发明能够使环磷酰胺所致免疫力低下小鼠CD4+T淋巴细胞的百分含量升高,使CD4+/CD8+的比值上升,提示本发明对T淋巴细胞免疫系统起正调节作用。IgG、IgM水平则反映了体液免疫能力。本研究表明山茱萸保健茶促进免疫力低下小鼠IgG、IgM分泌增加。说明本发明不但促进了机体细胞免疫功能的增强,同时对体液免疫也有促进作用。Thymus and spleen are important lymphatic organs of the body. The thymus is the place where T cells develop, differentiate and mature, and its structure and function are closely related to the state of the body. The reduction of thymus index and thymus atrophy are the manifestations of immunosuppression mainly of cellular immunity in mice. The spleen is the largest peripheral immune organ in the body. The immune cells of the spleen are mainly B lymphocytes, and B lymphocytes are the main cells involved in humoral immunity. Therefore, the spleen is closely related to the humoral immunity of the body. Thymus index and spleen index intuitively reflect the strength of immune body function. This experiment shows that the invention can promote the development of the spleen of mice with hypoimmunity induced by cyclophosphamide, and can also promote the development of the thymus to a certain extent. T lymphocytes can be divided into two subgroups, CD4+ and CD8+, according to their functions. CD4+ T lymphocytes play a very important central role in the body's immune response. It activates other T and B cell subsets and other cells participating in the immune response by secreting a variety of lymphokines, making them proliferate and differentiate, and coordinate the immune response. The interaction between cells plays a role in the body's immune system. An increase in the ratio of CD4+/CD8+ indicates that the positive regulation of the immune response is dominant, while a decrease in the ratio indicates that the immune function is low. The determination of T lymphocyte subsets in peripheral blood shows that the present invention can increase the percentage content of CD4+T lymphocytes in immunocompromised mice caused by cyclophosphamide, and increase the ratio of CD4+/CD8+, suggesting that the present invention Play a positive regulatory role on the T lymphocyte immune system. IgG, IgM levels reflect the humoral immunity. This study shows that the health-care tea of Cornus officinalis can promote the secretion of IgG and IgM in mice with low immunity. It shows that the present invention not only promotes the enhancement of the body's cellular immune function, but also promotes the humoral immunity.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610541739.2A CN106174561A (en) | 2016-07-10 | 2016-07-10 | Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610541739.2A CN106174561A (en) | 2016-07-10 | 2016-07-10 | Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106174561A true CN106174561A (en) | 2016-12-07 |
Family
ID=57474290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610541739.2A Withdrawn CN106174561A (en) | 2016-07-10 | 2016-07-10 | Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106174561A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301075A (en) * | 2008-06-06 | 2008-11-12 | 上海师范大学 | Immunity-enhancing functional food containing chive seeds and preparation method thereof |
CN104720067A (en) * | 2013-12-22 | 2015-06-24 | 陈永如 | Chinese medicinal herb essence granular drink and packaging method thereof |
CN105233056A (en) * | 2015-11-09 | 2016-01-13 | 青岛安倍康生物医药技术有限公司 | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid |
CN105341944A (en) * | 2015-11-28 | 2016-02-24 | 杨桂望 | Salvia miltiorrhiza oral liquid for improving immunity and preparation method thereof |
CN105410268A (en) * | 2015-11-28 | 2016-03-23 | 陈嗳 | Semen cuscutae health-care tea capable of improving eyesight and reducing blood lipid and preparation method of semen cuscutae health-care tea |
CN105727032A (en) * | 2016-03-30 | 2016-07-06 | 黄山树德堂食品饮料有限公司 | Health drink for pacifying liver and improving vision and preparation method thereof |
-
2016
- 2016-07-10 CN CN201610541739.2A patent/CN106174561A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301075A (en) * | 2008-06-06 | 2008-11-12 | 上海师范大学 | Immunity-enhancing functional food containing chive seeds and preparation method thereof |
CN104720067A (en) * | 2013-12-22 | 2015-06-24 | 陈永如 | Chinese medicinal herb essence granular drink and packaging method thereof |
CN105233056A (en) * | 2015-11-09 | 2016-01-13 | 青岛安倍康生物医药技术有限公司 | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid |
CN105341944A (en) * | 2015-11-28 | 2016-02-24 | 杨桂望 | Salvia miltiorrhiza oral liquid for improving immunity and preparation method thereof |
CN105410268A (en) * | 2015-11-28 | 2016-03-23 | 陈嗳 | Semen cuscutae health-care tea capable of improving eyesight and reducing blood lipid and preparation method of semen cuscutae health-care tea |
CN105727032A (en) * | 2016-03-30 | 2016-07-06 | 黄山树德堂食品饮料有限公司 | Health drink for pacifying liver and improving vision and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102068625B (en) | Traditional Chinese medicinal composition for reducing blood sugar and blood pressure and preparation method thereof | |
CN102145064B (en) | Traditional Chinese medicine composition for treating senile vaginitis and preparation method thereof | |
CN103734428B (en) | A kind of glossy privet fruit health-care tea improving immunity and preparation method thereof | |
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN103734426B (en) | A kind of Fructus Corni health protection tea of improving immunity and preparation method thereof | |
CN104305205B (en) | A kind of Semen Cuscutae oral liquid improving immunity and preparation method thereof | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN103405728A (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
CN102988675B (en) | Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof | |
CN104208623A (en) | Yao-nationality bathing medicine with effect of enhancing health after delivery of women and preparation method thereof | |
CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
CN106215118A (en) | Antineoplastic health preparation and preparation method thereof | |
CN104324310A (en) | Traditional Chinese medicine composition for treating mycotic keratitis after immune suppression and preparation method thereof | |
CN105233056A (en) | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid | |
CN111658720A (en) | Traditional Chinese medicine composition for health preservation, health preserving pill and preparation method | |
CN114712470B (en) | Medicine for treating deficiency of kidney of men and preparation method thereof | |
CN105998448A (en) | Method for preparing mulberry oral solution for improving immunity and oral solution prepared by same | |
CN106174561A (en) | Improve Rhizoma Curculiginis oral liquor and the oral liquid thereof of immunity | |
CN104432386A (en) | Loranthus parasiticus oral liquid for preventing soreness and weakness of waist and knees and weak muscles and bones and preparation method thereof | |
CN106174483A (en) | A kind of Rhizoma Curculiginis oral liquid improving immunity and preparation method thereof | |
CN110575466A (en) | Composition for increasing bone mineral density and application thereof | |
CN106237128A (en) | The Semen Cuscutae oral liquor of slow down aging and oral liquid thereof | |
CN106266672A (en) | A kind of Semen Cuscutae health care oral liquid of slow down aging and preparation method thereof | |
CN106110204A (en) | A kind of Herba Taraxaci oral liquid improving immunity and preparation method thereof | |
CN106109916A (en) | A kind of Fructus Rosae Laevigatae health care oral liquid of slow down aging and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161207 |
|
WW01 | Invention patent application withdrawn after publication |